TCR signaling (Homo sapiens)

From WikiPathways

Jump to: navigation, search
18, 31, 3694623, 34, 4211, 16, 631, 29442, 3512, 13, 56, 742014, 667, 6717, 6972995, 8, 409493, 37, 57, 68, 7313, 56722229, 459, 3978427910, 15, 24, 59, 7022, 33, 644, 535843, 5116, 63677929977, 7919, 28761, 29, 587841, 50, 52, 7113, 5625-27, 32, 5516, 6342613028nucleoplasmcytosolUb-580-UBC(533-608) HLA class II histocompatibility antigen, DP alpha chain precursor HLA class II histocompatibility antigen, DRB1-1 beta chain Antigen HLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DRB1-8 beta chain p-MAP3K7 p-Y771,Y783,Y1254-PLCG1 ITK UBE2V1 HLA class II histocompatibility antigen, DRB1-13 beta chain PiHLA class II histocompatibility antigen, DRB1-7 beta chain p-Y113,128,145-LCP2 HLA class II histocompatibility antigen, DRB1-16 beta chain HLA class II histocompatibility antigen, DP PSMB8 ATPBCL10 PSMC1 WAS RIPK2HLA class II histocompatibility antigen, DQ beta 2 chain PDPK1 HLA class II histocompatibility antigen, DRB1-16 beta chain SLP-76 bound toGads:LATPAK3 Ub-124-UBC(77-152) PAK3 PIK3R2 p-T184,T187-MAP3K7 HLA class II histocompatibility antigen, DR beta 4 chain HLA class II histocompatibility antigen, DRB1-11 beta chain HLA class II histocompatibility antigen, DQ TRAC TRAV19 p-6Y-CD247 CD4 HLA class II histocompatibility antigen, DRB1-11 beta chain p-S552-CARD11 CD3D HLA class II histocompatibility antigen, DRB1-9 beta chain precursor HLA class II histocompatibility antigen, DR beta 5 chain TRAC HLA class II histocompatibility antigen, DR-1 beta chain precursor ADPTRBV12-3 TCRA CD45,CD148TRBC1 GRAP2 p-5Y-LAT GRAP2 ADPK63polyUb-NEMO CHUK HLA class II histocompatibility antigen, DRB1-12 beta chain ATPUb-48-RPS27A(1-76) T-cell receptor alpha chain V region PY14 precursor PSMD12 UBE2N HLA class II histocompatibility antigen, DRB1-8 beta chain HLA class II histocompatibility antigen, DRB1-8 beta chain VASP Ena/VASP proteinsp-Y188,Y199-CD3E p-S552-CARD11 HLA class II histocompatibility antigen, DRB1-1 beta chain TRBC1 MALT1 H2OIKBKG p-Y753,Y759,Y1217-PLCG2 SCF-beta-TRCPCD4 HLA class II histocompatibility antigen, DQ K63polyUbNCK1 H2Op-5Y-LAT BTRC ATPHLA class II histocompatibility antigen, DRB1-14 beta chain HLA class II histocompatibility antigen, DRB1-7 beta chain CD3G ITK:p-Y113,128,145-SLP-76:GADS:LATBCL10ATPHLA class II histocompatibility antigen, DRB1-9 beta chain precursor PTPRJ HLA class II histocompatibility antigen, DP alpha chain precursor p-Y394-LCK HLA class II histocompatibility antigen, DR-1 beta chain precursor HLA class II histocompatibility antigen, DQ beta 2 chain ITKHLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DRB1-1 beta chain ATPPI(3,4,5)P3 p-5Y-LAT HLA class II histocompatibility antigen, DRB1-10 beta chain TCRB HLA class II histocompatibility antigen, DRB1-13 beta chain TCRA p-5Y-LAT ATPPLCG1 PSMD7 CD3G HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor NFKB1(1-433) HLA class II histocompatibility antigen, DRB1-13 beta chain p-Y160,Y171-CD3G HLA class II histocompatibility antigen, DQ beta 2 chain p-Y90,T538,S676,S695-PRKCQ HLA class II histocompatibility antigen, DRB1-10 beta chain p-S177,S181-IKKB:IKKA:pUb-NEMOHLA class II histocompatibility antigen, DRB1-15 beta chain HLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DRB1-10 beta chain ADPPAK2 ATPp-Y771,Y783,Y1254-PLCG1 HLA class II histocompatibility antigen, DRB1-7 beta chain PSME4 HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor HLA class II histocompatibility antigen, DQ ENAH p-Y188,Y199-CD3E ZAP-70 and ITKtyrosine kinasesTRAV19 p-S552-CARD11 TRBC1 HLA class II histocompatibility antigen, DRB1-15 beta chain HLA class II histocompatibility antigen, DRB1-1 beta chain Ub-352-UBC(305-380) T-cell receptor alpha chain V region PY14 precursor HLA class II histocompatibility antigen, DP alpha chain precursor HLA class II histocompatibility antigen, DRB1-15 beta chain PSMD13 PTPRC CD4 Ub-48-UBB(1-76) Antigen HLA class II histocompatibility antigen, DRB1-14 beta chain HLA class II histocompatibility antigen, DRB1-1 beta chain LCP2HLA class II histocompatibility antigen, DR-1 beta chain precursor HLA class II histocompatibility antigen, DQ NCK1 p-S177,S181-IKBKB HLA class II histocompatibility antigen, DRB1-16 beta chain PI(4,5)P2HLA class II histocompatibility antigen, DQ SKP1 Antigen CHUK TAB2/TAK1 complexRELA p-Y113,128,145-LCP2 TRBV12-3 K48-UbRELA HLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DR beta 5 chain HLA class II histocompatibility antigen, DP alpha chain precursor TRAC HLA class II histocompatibility antigen, DP alpha chain precursor PLCG1 p-Y315,Y493-ZAP70 ADPTRBV12-3 ATPHLA class II histocompatibility antigen, DR-1 beta chain precursor HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DR beta 5 chain HLA class II histocompatibility antigen, DR beta 5 chain DAGs p-Y160,Y171-CD3G p-Y160,Y171-CD3G UBE2D1 p-BCL10 p-Y160,Y171-CD3G CD3G p-Y315,Y493-ZAP70 NFKB1(1-433) CD247-1 HLA class II histocompatibility antigen, DRB3-1 beta chain precursor HLA class II histocompatibility antigen, DP PSMA3 HLA class II histocompatibility antigen, DRB1-4 beta chain LATPDK1:PIP2,PIP3TRBV12-3 Antigen-bearing MHCClass II : TCRcomplex:CD4:Lckp-5Y-LAT p-Y90-PKC-theta:DAGGRAP2FYB HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor p-Y394-LCK p-Y149,Y160-CD3D HLA class II histocompatibility antigen, DR beta 4 chain PI(3,4)P2 HLA class II histocompatibility antigen, DRB1-4 beta chain p-Y394-LCK HLA class II histocompatibility antigen, DQ TCRA HLA class II histocompatibility antigen, DRB1-7 beta chain Ub-48-UBC(1-76) PSMA8 p-6Y-CD247 FYBTRBV12-3 p-Y394-LCK HLA class II histocompatibility antigen, DR alpha chain precursor p-Y317-PAG1 PSME3 HLA class II histocompatibility antigen, DRB1-11 beta chain PI(3,4,5)P3 HLA class II histocompatibility antigen, DRB1-8 beta chain PI3KHLA class II histocompatibility antigen, DRB1-15 beta chain TRAC HLA class II histocompatibility antigen, DRB1-8 beta chain TRAV19 HLA class II histocompatibility antigen, DRB1-16 beta chain HLA class II histocompatibility antigen, DRB1-10 beta chain HLA class II histocompatibility antigen, DP alpha chain precursor CUL1 GRAP2 p-Y113,128,145-LCP2 p-Y188,Y199-CD3E ATPDAGs p-Y113,128,145-LCP2 GADS:p-5Y-LATEVL NCK1TRBC1 TAB2 TCRB HLA class II histocompatibility antigen, DR beta 5 chain PI(3,4,5)P3 PSMB5 TRBC1 DAGs HLA class II histocompatibility antigen, DR-1 beta chain precursor HLA class II histocompatibility antigen, DRB1-14 beta chain HLA class II histocompatibility antigen, DRB3-1 beta chain precursor HLA class II histocompatibility antigen, DRB1-12 beta chain TRBV12-3 CSKTCRA Ub-656-UBC(609-684) PI(3,4,5)P3 HLA class II histocompatibility antigen, DR beta 5 chain p-5Y-LAT HLA class II histocompatibility antigen, DRB1-13 beta chain ATPPSMC5 HLA class II histocompatibility antigen, DRB1-4 beta chain PIK3CA HLA class II histocompatibility antigen, DR alpha chain precursor HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DP PLCG1HLA class II histocompatibility antigen, DQ beta 2 chain phosphorylatedPLC-gamma1 bound toSLP-76PIK3CA TAK1/TAB2 complexbound to TRAF6/CBMcomplexPI(3,4)P2p-Y90-PRKCQ p-6Y-CD247 p-Y113,128,145-LCP2 I(1,4,5)P3p-S552-CARD11 PDPK1 TRAC CD4 HLA class II histocompatibility antigen, DRB1-10 beta chain CARMA1 trimerMALT1 trimer boundto Bcl10 and CARMA1trimerATPHLA class II histocompatibility antigen, DR beta 5 chain CD4 PSMD11 HLA class II histocompatibility antigen, DP PI(3,4,5)P3 phosphorylatedPLC-gamma1 bound toLATPSMA5 PLCG1 ADPHLA class II histocompatibility antigen, DRB1-7 beta chain PI(3,4)P2 HLA class II histocompatibility antigen, DQ beta 2 chain IkB(alpha):NF-kBcomplexHLA class II histocompatibility antigen, DRB3-1 beta chain precursor HLA class II histocompatibility antigen, DRB1-13 beta chain HLA class II histocompatibility antigen, DR-1 beta chain precursor CD3D UBE2N:UBE2V1ADPHLA class II histocompatibility antigen, DRB1-1 beta chain PDPK1 p-Y113,128,145-LCP2 PI(3,4,5)P3 p-BCL10HLA class II histocompatibility antigen, DQ beta 2 chain HLA class II histocompatibility antigen, DQ TRAV19 Ub-276-UBC(229-304) HLA class II histocompatibility antigen, DQ PSMA7 Bcl10 trimer boundto CARMA1 trimerPI(3,4)P2 p-SLP-76:NCK:PAKCD247-1 PI(3,4,5)P3 CD4 Antigen-bearing MHCClass II :TCRcomplex:CD4: Lckphosphorylated atTyr394TRBC1 TCRB HLA class II histocompatibility antigen, DP p-S552-CARD11 GRAP2 p-S552-CARD11 HLA class II histocompatibility antigen, DRB3-1 beta chain precursor Antigen-bearingMHCClassII:TCRcomplex:CD4:p-Lck(Y505)LCP2 PSMF1 PDPK1 IKBKG PTPN22Ub-200-UBB(153-228) HLA class II histocompatibility antigen, DRB1-14 beta chain RELA HLA class II histocompatibility antigen, DQ beta 2 chain CDC34 TRAF6CHUK Ub-TRAF6 trimerbound to CBMcomplexHLA class II histocompatibility antigen, DRB1-14 beta chain HLA class II histocompatibility antigen, DRB1-9 beta chain precursor ADPPIK3R1 p-Y113,128,145-LCP2 PLCG1:p-5Y-LATHLA class II histocompatibility antigen, DRB1-7 beta chain Antigen p-Y317-PAG1HLA class II histocompatibility antigen, DQ H2OPDPK1 PI(4,5)P2HLA class II histocompatibility antigen, DRB1-4 beta chain ZAP-70 bound tophosphorylated ITAMmotifsHLA class II histocompatibility antigen, DRB1-10 beta chain TCRB PSMA4 MALT1 HLA class II histocompatibility antigen, DRB1-16 beta chain PSMB1 HLA class II histocompatibility antigen, DR alpha chain precursor PSMD6 Antigen-bearing MHCClass II :TCRcomplex:CD4: Lckphosphorylated atTyr394MALT1 p-5Y-LAT p-5Y-LAT HLA class II histocompatibility antigen, DQ PSMB3 PI(4,5)P2TRBV12-3 HLA class II histocompatibility antigen, DQ beta 2 chain HLA class II histocompatibility antigen, DRB1-11 beta chain NFKB1(1-433):RELAHLA class II histocompatibility antigen, DRB1-9 beta chain precursor T-cell receptor alpha chain V region PY14 precursor HLA class II histocompatibility antigen, DR alpha chain precursor PI(3,4)P2 PTPN22 ADPPTPN22:CSKNFKB1(1-433) HLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DRB1-11 beta chain TCRB RELA RELA HLA class II histocompatibility antigen, DRB1-7 beta chain p-Y113,128,145-SLP-76:GADS:LATZAP70HLA class II histocompatibility antigen, DRB1-16 beta chain HLA class II histocompatibility antigen, DRB1-16 beta chain HLA class II histocompatibility antigen, DRB1-15 beta chain Ub-504-UBC(457-532) TRAV19 EVL PSMD3 HLA class II histocompatibility antigen, DRB1-8 beta chain p-Y63,Y79,Y110-TRAT1 TCRB HLA class II histocompatibility antigen, DRB1-1 beta chain PSMD9 HLA class II histocompatibility antigen, DRB1-9 beta chain precursor TRBC1 NFKB1(1-433) PI(3,4)P2 Active PKC thetabound to DAGFBXW11 TCRA p-5Y-LAT PIK3CB HLA class II histocompatibility antigen, DRB1-11 beta chain HLA class II histocompatibility antigen, DRB1-9 beta chain precursor PIP3 activates AKTsignalingHLA class II histocompatibility antigen, DRB1-15 beta chain PKC-theta (open):DAGHLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DRB1-8 beta chain HLA class II histocompatibility antigen, DP alpha chain precursor HLA class II histocompatibility antigen, DRB1-13 beta chain CD4 p-Y149,Y160-CD3D PSMA6 K63polyUbADPMALT1 trimerp-BCL10 PAK1,2,3HLA class II histocompatibility antigen, DRB3-1 beta chain precursor PSMD2 p-Y149,Y160-CD3D p-S552-CARD11 p-Y771,Y783,Y1254-PLCG1PSMD10 HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor p-SLP-76:ADAP:Ena/VASPPI(3,4)P2 MALT1 PDPK1 HLA class II histocompatibility antigen, DRB1-11 beta chain HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DRB1-9 beta chain precursor PRKCQ PI(3,4)P2 HLA class II histocompatibility antigen, DR alpha chain precursor PSMC3 p-BCL10 HLA class II histocompatibility antigen, DQ ADPHLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DRB1-8 beta chain HLA class II histocompatibility antigen, DP ENAH HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor Ub-428-UBC(381-456) HLA class II histocompatibility antigen, DR beta 5 chain PSMB10 p-Y160,Y171-CD3G HLA class II histocompatibility antigen, DRB1-15 beta chain CARMA1 bound to PDK1HLA class II histocompatibility antigen, DRB1-8 beta chain HLA class II histocompatibility antigen, DRB1-13 beta chain HLA class II histocompatibility antigen, DQ beta 2 chain CARD11 HLA class II histocompatibility antigen, DRB1-11 beta chain GRAP2 HLA class II histocompatibility antigen, DRB1-4 beta chain HLA class II histocompatibility antigen, DRB3-1 beta chain precursor PSMD4 PSMC6 HLA class II histocompatibility antigen, DRB3-1 beta chain precursor HLA class II histocompatibility antigen, DRB1-1 beta chain p-6Y-CD247 HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DR beta 4 chain p-S552-CARD11HLA class II histocompatibility antigen, DQ PLC-gamma1 bound toLAT or SLP-76HLA class II histocompatibility antigen, DRB1-9 beta chain precursor HLA class II histocompatibility antigen, DRB1-13 beta chain HLA class II histocompatibility antigen, DP UBE2N Activated ZAP-70p-Y493-ZAP70 HLA class II histocompatibility antigen, DRB1-4 beta chain PRKQC closedconformationPIK3R1 CD3E WASTRAC CD3E PI(3,4)P2 HLA class II histocompatibility antigen, DR beta 4 chain CSK ITK p-Y149,Y160-CD3D HLA class II histocompatibility antigen, DR-1 beta chain precursor HLA class II histocompatibility antigen, DR alpha chain precursor T-cell receptor alpha chain V region PY14 precursor TRAC p-Y113,128,145-LCP2 HLA class II histocompatibility antigen, DR beta 4 chain MALT1 H2OTRBV12-3 PDPK1 HLA class II histocompatibility antigen, DRB3-1 beta chain precursor PSME1 PSMB7 ADPUb-48-UBA52(1-76) HLA class II histocompatibility antigen, DP alpha chain precursor p-SLP-76:ADAPPDPK1 CARD11PI(3,4,5)P3 CSK HLA class II histocompatibility antigen, DRB3-1 beta chain precursor HLA class II histocompatibility antigen, DP alpha chain precursor HLA class II histocompatibility antigen, DRB1-11 beta chain HLA class II histocompatibility antigen, DRB1-7 beta chain p-Y505-LCK p-Y771,Y783,Y1254-PLCG1 CD3E ADPAntigen T-cell receptor alpha chain V region PY14 precursor p-S177,S181-IKKB:IKKA:NEMOPI(3,4)P2 PDPK1 UBE2N:UBE2V1p-SLP-76:NCK1:WASPp-4Y-PLCG1 p-Y113,128,145-LCP2 p-S552-CARD11 PAK1 p-Y113,128,145-LCP2 HLA class II histocompatibility antigen, DRB1-9 beta chain precursor HLA class II histocompatibility antigen, DRB1-16 beta chain HLA class II histocompatibility antigen, DQ p-Y394-LCK TRBC1 HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor p-Y113,128,145-LCP2 p-SLP-76:NCK1PI(3,4)P2 TCRB HLA class II histocompatibility antigen, DRB1-14 beta chain Activated CARMA1K48PolyUb-K21,22-p-S32,S36-IkBA TCRA p-PLCGNFKB1(1-433) ATPHLA class II histocompatibility antigen, DQB1*0602 beta chain precursor PSMD5 p-Y188,Y199-CD3E CD3G PAK2 K63polyUb-TRAF6 p-4Y-PLCG1 ADPADPPSMC4 TRAV19 HLA class II histocompatibility antigen, DR alpha chain precursor IKBKB ATPPI(3,4,5)P3PSME2 TRAF6 PiPI(3,4,5)P3 H2OTCRB TCRA HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DRB1-10 beta chain CD3E TRBV12-3 PSMD1 DAGsATPTRAV19 p-5Y-LAT p-BCL10 K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complexCD101PAK1 HLA class II histocompatibility antigen, DQ p-BCL10 HLA class II histocompatibility antigen, DRB1-15 beta chain PSMB2 UBE2D2,UBE2D1,(CDC34)PI(3,4,5)P3 HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor HLA class II histocompatibility antigen, DRB1-14 beta chain NFKBIA TRAC Phosphorylated Bcl10bound to CARMA1 andRIP2ATPp-S32,36-IkB-alpha:NF-kB complexUb-200-UBC(153-228) HLA class II histocompatibility antigen, DRB1-13 beta chain UBE2D2 HLA class II histocompatibility antigen, DR alpha chain precursor TRAV19 p-5Y-LAT Bcl10 bound toCARMA1T-cell receptor alpha chain V region PY14 precursor HLA class II histocompatibility antigen, DR alpha chain precursor 26S proteasomeUb-124-UBB(77-152) p-BCL10 DAGsHLA class II histocompatibility antigen, DRB1-4 beta chain phospho tyrosineZAP-70p-Y149,Y160-CD3D HLA class II histocompatibility antigen, DRB1-10 beta chain HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor PI(3,4,5)P3 p-6Y-CD247 CD4 CD247-1 p-Y394-LCK ADPAntigen GRAP2 HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DQ HLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DRB1-14 beta chain p-Y188,Y199-CD3E TRAV19 HLA class II histocompatibility antigen, DP CD4 TRAC PDPK1p-S177,S181-IKBKB TCRA HLA class II histocompatibility antigen, DQ PSMC2 HLA class II histocompatibility antigen, DR beta 4 chain PLCG1:p-3Y-SLP-76:Gads:LATPIK3CB p-S32,S36-NFKBIA HLA class II histocompatibility antigen, DRB1-7 beta chain PSMD8 K63polyUb-TRAF6 HLA class II histocompatibility antigen, DRB1-4 beta chain ZAP70 VASP GRAP2 PDPK1 HLA class II histocompatibility antigen, DR-1 beta chain precursor Csk:p-PAGINPP5Dp-Y113,128,145-LCP2HLA class II histocompatibility antigen, DQ GRAP2 Antigen-bearing MHCClass II: TCR withphosphorylatedITAMs:CD4p-Y63,Y79,Y110-TRAT1PI(3,4)P2 CD3D p-Y394-LCK p-5Y-LATCD3D TCRA PSMA2 Activated PLC gamma1bound to PIP2HLA class II histocompatibility antigen, DRB1-12 beta chain HLA class II histocompatibility antigen, DRB1-1 beta chain HLA class II histocompatibility antigen, DR beta 5 chain UBE2V1 HLA class II histocompatibility antigen, DQ NCK1 HLA class II histocompatibility antigen, DRB1-4 beta chain HLA class II histocompatibility antigen, DRB1-10 beta chain p-Y113,128,145-LCP2 PSMB6 GRAP2 T-cell receptor alpha chain V region PY14 precursor TAB2 PDPK1 HLA class II histocompatibility antigen, DRB1-15 beta chain T-cell receptor alpha chain V region PY14 precursor HLA class II histocompatibility antigen, DR-1 beta chain precursor PiFYB HLA class II histocompatibility antigen, DP PI(3,4,5)P3 CHUK:IKBKB:IKBKGPI(4,5)P2 ATPNFKB1(1-433):RELAPSMB11 PSMA1 Antigen TCRB PSMB4 T-cell receptor alpha chain V region PY14 precursor p-S552-CARD11 HLA class II histocompatibility antigen, DRB1-16 beta chain HLA class II histocompatibility antigen, DQ PSMD14 Antigen PIK3R2 HLA class II histocompatibility antigen, DR beta 4 chain SHFM1 LCK PSMB9 Antigen HLA class II histocompatibility antigen, DR beta 4 chain HLA class II histocompatibility antigen, DR beta 4 chain PTENCD247-1 PIP3, PI(3,4)P2ADPPhosphorylatedPLC-gamma1 bound toLAT or SLP-76PI3K bound to TRATTRBC1 TRAF6 trimer boundto CBM complexHLA class II histocompatibility antigen, DRB1-14 beta chain PI(3,4)P2 77738, 47, 65212148, 75496021216121602149542161, 6248


Description

The TCR is a multisubunit complex that consists of clonotypic alpha/beta chains noncovalently associated with the invariant CD3 delta/epsilon/gamma and TCR zeta chains. T cell activation by antigen presenting cells (APCs) results in the activation of protein tyrosine kinases (PTKs) that associate with CD3 and TCR zeta subunits and the co-receptor CD4. Members of the Src kinases (Lck), Syk kinases (ZAP-70), Tec (Itk) and Csk families of nonreceptor PTKs play a crucial role in T cell activation. Activation of PTKs following TCR engagement results in the recruitment and tyrosine phosphorylation of enzymes such as phospholipase C gamma1 and Vav as well as critical adaptor proteins such as LAT, SLP-76 and Gads. These proximal activation leads to reorganization of the cytoskeleton as well as transcription activation of multiple genes leading to T lymphocyte proliferation, differentiation and/or effector function. View original pathway at Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 202403
Reactome-version 
Reactome version: 75
Reactome Author 
Reactome Author: Rudd, Christopher, de Bono, Bernard, Garapati, Phani Vijay

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Thome M.; ''CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.''; PubMed Europe PMC Scholia
  2. Bokoch GM, Wang Y, Bohl BP, Sells MA, Quilliam LA, Knaus UG.; ''Interaction of the Nck adapter protein with p21-activated kinase (PAK1).''; PubMed Europe PMC Scholia
  3. Kabuyama Y, Nakatsu N, Homma Y, Fukui Y.; ''Purification and characterization of the phosphatidylinositol-3,4,5-trisphosphate phosphatase in bovine thymus.''; PubMed Europe PMC Scholia
  4. Wilkinson B, Downey JS, Rudd CE.; ''T-cell signalling and immune system disorders.''; PubMed Europe PMC Scholia
  5. Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE.; ''Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling.''; PubMed Europe PMC Scholia
  6. Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J.; ''Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton.''; PubMed Europe PMC Scholia
  7. Vang T, Liu WH, Delacroix L, Wu S, Vasile S, Dahl R, Yang L, Musumeci L, Francis D, Landskron J, Tasken K, Tremblay ML, Lie BA, Page R, Mustelin T, Rahmouni S, Rickert RC, Tautz L.; ''LYP inhibits T-cell activation when dissociated from CSK.''; PubMed Europe PMC Scholia
  8. Wange RL.; ''LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways.''; PubMed Europe PMC Scholia
  9. Kim MJ, Kim E, Ryu SH, Suh PG.; ''The mechanism of phospholipase C-gamma1 regulation.''; PubMed Europe PMC Scholia
  10. Bonizzi G, Karin M.; ''The two NF-kappaB activation pathways and their role in innate and adaptive immunity.''; PubMed Europe PMC Scholia
  11. Mustelin T, Taskén K.; ''Positive and negative regulation of T-cell activation through kinases and phosphatases.''; PubMed Europe PMC Scholia
  12. Liu Y, Graham C, Parravicini V, Brown MJ, Rivera J, Shaw S.; ''Protein kinase C theta is expressed in mast cells and is functionally involved in Fcepsilon receptor I signaling.''; PubMed Europe PMC Scholia
  13. Altman A, Villalba M.; ''Protein kinase C-theta (PKC theta): a key enzyme in T cell life and death.''; PubMed Europe PMC Scholia
  14. Marinari B, Simeoni L, Schraven B, Piccolella E, Tuosto L.; ''The activation of Csk by CD4 interferes with TCR-mediated activatory signaling.''; PubMed Europe PMC Scholia
  15. Chen ZJ, Parent L, Maniatis T.; ''Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.''; PubMed Europe PMC Scholia
  16. Chu DH, Morita CT, Weiss A.; ''The Syk family of protein tyrosine kinases in T-cell activation and development.''; PubMed Europe PMC Scholia
  17. March ME, Ravichandran K.; ''Regulation of the immune response by SHIP.''; PubMed Europe PMC Scholia
  18. Rudd CE.; ''Adaptors and molecular scaffolds in immune cell signaling.''; PubMed Europe PMC Scholia
  19. Boggon TJ, Eck MJ.; ''Structure and regulation of Src family kinases.''; PubMed Europe PMC Scholia
  20. Vanhaesebroeck B, Alessi DR.; ''The PI3K-PDK1 connection: more than just a road to PKB.''; PubMed Europe PMC Scholia
  21. Streuli M, Hall LR, Saga Y, Schlossman SF, Saito H.; ''Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.''; PubMed Europe PMC Scholia
  22. Koyasu S.; ''The role of PI3K in immune cells.''; PubMed Europe PMC Scholia
  23. Chen ZJ.; ''Ubiquitin signalling in the NF-kappaB pathway.''; PubMed Europe PMC Scholia
  24. Shambharkar PB, Blonska M, Pappu BP, Li H, You Y, Sakurai H, Darnay BG, Hara H, Penninger J, Lin X.; ''Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.''; PubMed Europe PMC Scholia
  25. Zikherman J, Jenne C, Watson S, Doan K, Raschke W, Goodnow CC, Weiss A.; ''CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development.''; PubMed Europe PMC Scholia
  26. Cordoba SP, Choudhuri K, Zhang H, Bridge M, Basat AB, Dustin ML, van der Merwe PA.; ''The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor.''; PubMed Europe PMC Scholia
  27. Ostergaard HL, Shackelford DA, Hurley TR, Johnson P, Hyman R, Sefton BM, Trowbridge IS.; ''Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines.''; PubMed Europe PMC Scholia
  28. Palacios EH, Weiss A.; ''Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.''; PubMed Europe PMC Scholia
  29. Thome M, Weil R.; ''Post-translational modifications regulate distinct functions of CARMA1 and BCL10.''; PubMed Europe PMC Scholia
  30. Bubeck Wardenburg J, Pappu R, Bu JY, Mayer B, Chernoff J, Straus D, Chan AC.; ''Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76.''; PubMed Europe PMC Scholia
  31. Rudd CE, Schneider H.; ''Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.''; PubMed Europe PMC Scholia
  32. Leo A, Wienands J, Baier G, Horejsi V, Schraven B.; ''Adapters in lymphocyte signaling.''; PubMed Europe PMC Scholia
  33. Bruyns E, Marie-Cardine A, Kirchgessner H, Sagolla K, Shevchenko A, Mann M, Autschbach F, Bensussan A, Meuer S, Schraven B.; ''T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane.''; PubMed Europe PMC Scholia
  34. Adhikari A, Xu M, Chen ZJ.; ''Ubiquitin-mediated activation of TAK1 and IKK.''; PubMed Europe PMC Scholia
  35. Galisteo ML, Chernoff J, Su YC, Skolnik EY, Schlessinger J.; ''The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1.''; PubMed Europe PMC Scholia
  36. van Leeuwen JE, Samelson LE.; ''T cell antigen-receptor signal transduction.''; PubMed Europe PMC Scholia
  37. Das S, Dixon JE, Cho W.; ''Membrane-binding and activation mechanism of PTEN.''; PubMed Europe PMC Scholia
  38. Rothwarf DM, Zandi E, Natoli G, Karin M.; ''IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.''; PubMed Europe PMC Scholia
  39. Yablonski D, Kadlecek T, Weiss A.; ''Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT.''; PubMed Europe PMC Scholia
  40. Rudd CE, Wang H.; ''Hematopoietic adaptors in T-cell signaling: potential applications to transplantation.''; PubMed Europe PMC Scholia
  41. Baldi L, Brown K, Franzoso G, Siebenlist U.; ''Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha.''; PubMed Europe PMC Scholia
  42. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ.; ''The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.''; PubMed Europe PMC Scholia
  43. Boerth NJ, Judd BA, Koretzky GA.; ''Functional association between SLAP-130 and SLP-76 in Jurkat T cells.''; PubMed Europe PMC Scholia
  44. Gilmore TD.; ''Introduction to NF-kappaB: players, pathways, perspectives.''; PubMed Europe PMC Scholia
  45. Rueda D, Thome M.; ''Phosphorylation of CARMA1: the link(er) to NF-kappaB activation.''; PubMed Europe PMC Scholia
  46. Kroll M, Conconi M, Desterro MJ, Marin A, Thomas D, Friguet B, Hay RT, Virelizier JL, Arenzana-Seisdedos F, Rodriguez MS.; ''The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.''; PubMed Europe PMC Scholia
  47. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ, Wang RF.; ''NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.''; PubMed Europe PMC Scholia
  48. Kim YJ, Sekiya F, Poulin B, Bae YS, Rhee SG.; ''Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2.''; PubMed Europe PMC Scholia
  49. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG.; ''Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.''; PubMed Europe PMC Scholia
  50. Spencer E, Jiang J, Chen ZJ.; ''Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP.''; PubMed Europe PMC Scholia
  51. Musci MA, Hendricks-Taylor LR, Motto DG, Paskind M, Kamens J, Turck CW, Koretzky GA.; ''Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.''; PubMed Europe PMC Scholia
  52. Carter RS, Pennington KN, Ungurait BJ, Arrate P, Ballard DW.; ''Signal-induced ubiquitination of I kappaB Kinase-beta.''; PubMed Europe PMC Scholia
  53. Huang Y, Wange RL.; ''T cell receptor signaling: beyond complex complexes.''; PubMed Europe PMC Scholia
  54. Latres E, Chiaur DS, Pagano M.; ''The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.''; PubMed Europe PMC Scholia
  55. Stepanek O, Kalina T, Draber P, Skopcova T, Svojgr K, Angelisova P, Horejsi V, Weiss A, Brdicka T.; ''Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148.''; PubMed Europe PMC Scholia
  56. Manicassamy S, Gupta S, Sun Z.; ''Selective function of PKC-theta in T cells.''; PubMed Europe PMC Scholia
  57. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP.; ''Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.''; PubMed Europe PMC Scholia
  58. Lin X, Wang D.; ''The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.''; PubMed Europe PMC Scholia
  59. Hayden MS, Ghosh S.; ''Signaling to NF-kappaB.''; PubMed Europe PMC Scholia
  60. Chan AC, Iwashima M, Turck CW, Weiss A.; ''ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain.''; PubMed Europe PMC Scholia
  61. Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
  62. Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
  63. van Oers NS, Weiss A.; ''The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes.''; PubMed Europe PMC Scholia
  64. Kölsch U, Arndt B, Reinhold D, Lindquist JA, Jüling N, Kliche S, Pfeffer K, Bruyns E, Schraven B, Simeoni L.; ''Normal T-cell development and immune functions in TRIM-deficient mice.''; PubMed Europe PMC Scholia
  65. Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K, Baeuerle PA, Scheidereit C.; ''The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.''; PubMed Europe PMC Scholia
  66. Brdicka T, Pavlistová D, Leo A, Bruyns E, Korínek V, Angelisová P, Scherer J, Shevchenko A, Hilgert I, Cerný J, Drbal K, Kuramitsu Y, Kornacker B, Horejsí V, Schraven B.; ''Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.''; PubMed Europe PMC Scholia
  67. Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT, Tang J, Jeffery D, Mortara K, Sampang J, Williams SR, Buggy J, Clark JM.; ''Identification of substrates of human protein-tyrosine phosphatase PTPN22.''; PubMed Europe PMC Scholia
  68. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK.; ''The lipid phosphatase activity of PTEN is critical for its tumor supressor function.''; PubMed Europe PMC Scholia
  69. Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM.; ''Structure, function, and biology of SHIP proteins.''; PubMed Europe PMC Scholia
  70. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M.; ''A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.''; PubMed Europe PMC Scholia
  71. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y.; ''Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.''; PubMed Europe PMC Scholia
  72. Liu SK, Berry DM, McGlade CJ.; ''The role of Gads in hematopoietic cell signalling.''; PubMed Europe PMC Scholia
  73. Maehama T, Dixon JE.; ''The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.''; PubMed Europe PMC Scholia
  74. Melowic HR, Stahelin RV, Blatner NR, Tian W, Hayashi K, Altman A, Cho W.; ''Mechanism of diacylglycerol-induced membrane targeting and activation of protein kinase Ctheta.''; PubMed Europe PMC Scholia
  75. Sekiya F, Poulin B, Kim YJ, Rhee SG.; ''Mechanism of tyrosine phosphorylation and activation of phospholipase C-gamma 1. Tyrosine 783 phosphorylation is not sufficient for lipase activation.''; PubMed Europe PMC Scholia
  76. Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC.; ''Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains.''; PubMed Europe PMC Scholia
  77. Sebban-Benin H, Pescatore A, Fusco F, Pascuale V, Gautheron J, Yamaoka S, Moncla A, Ursini MV, Courtois G.; ''Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.''; PubMed Europe PMC Scholia
  78. Qi Q, August A.; ''Keeping the (kinase) party going: SLP-76 and ITK dance to the beat.''; PubMed Europe PMC Scholia
  79. Häcker H, Karin M.; ''Regulation and function of IKK and IKK-related kinases.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114986view16:51, 25 January 2021ReactomeTeamReactome version 75
113430view11:50, 2 November 2020ReactomeTeamReactome version 74
112632view16:01, 9 October 2020ReactomeTeamReactome version 73
101547view11:41, 1 November 2018ReactomeTeamreactome version 66
101082view21:24, 31 October 2018ReactomeTeamreactome version 65
100611view19:58, 31 October 2018ReactomeTeamreactome version 64
100162view16:43, 31 October 2018ReactomeTeamreactome version 63
99712view15:11, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93802view13:37, 16 August 2017ReactomeTeamreactome version 61
93340view11:20, 9 August 2017ReactomeTeamreactome version 61
86427view09:17, 11 July 2016ReactomeTeamreactome version 56
83133view10:06, 18 November 2015ReactomeTeamVersion54
81476view13:00, 21 August 2015ReactomeTeamVersion53
76950view08:22, 17 July 2014ReactomeTeamFixed remaining interactions
76655view12:02, 16 July 2014ReactomeTeamFixed remaining interactions
75984view10:04, 11 June 2014ReactomeTeamRe-fixing comment source
75687view11:02, 10 June 2014ReactomeTeamReactome 48 Update
75043view13:55, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74687view08:45, 30 April 2014ReactomeTeamReactome46
68930view17:33, 8 July 2013MaintBotUpdated to 2013 gpml schema
45094view21:15, 6 October 2011KhanspersOntology Term : 'T cell receptor signaling pathway' added !
42142view22:00, 4 March 2011MaintBotAutomatic update
39953view05:58, 21 January 2011MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
26S proteasomeComplexR-HSA-68819 (Reactome)
ADPMetaboliteCHEBI:456216 (ChEBI)
ATPMetaboliteCHEBI:30616 (ChEBI)
Activated CARMA1ComplexR-HSA-202440 (Reactome)
Activated PLC gamma1 bound to PIP2ComplexR-HSA-202269 (Reactome)
Activated ZAP-70ComplexR-HSA-202181 (Reactome)
Active PKC theta bound to DAGComplexR-HSA-202442 (Reactome)
Antigen R-ALL-173548 (Reactome)
Antigen-bearing

MHC Class II

TCR

complex:CD4:p-Lck(Y505)		ComplexR-HSA-202154 (Reactome)
Antigen-bearing MHC

Class II  : TCR

complex:CD4:Lck		ComplexR-HSA-202157 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		ComplexR-HSA-202266 (Reactome)
Antigen-bearing MHC

Class II: TCR with phosphorylated

ITAMs:CD4		ComplexR-HSA-203494 (Reactome)
BCL10 ProteinO95999 (Uniprot-TrEMBL)
BCL10ProteinO95999 (Uniprot-TrEMBL)
BTRC ProteinQ9Y297 (Uniprot-TrEMBL)
Bcl10 bound to CARMA1ComplexR-HSA-202454 (Reactome) Bcl10 interacts with the oligomerized CARMA1 and this is mediated by the CARD-CARD domainn interaction.
Bcl10 trimer bound to CARMA1 trimerComplexR-HSA-202475 (Reactome)
CARD11 ProteinQ9BXL7 (Uniprot-TrEMBL)
CARD11ProteinQ9BXL7 (Uniprot-TrEMBL)
CARMA1 bound to PDK1ComplexR-HSA-202349 (Reactome)
CARMA1 trimerComplexR-HSA-202445 (Reactome)
CD101ProteinQ93033 (Uniprot-TrEMBL)
CD247-1 ProteinP20963-1 (Uniprot-TrEMBL)
CD3D ProteinP04234 (Uniprot-TrEMBL)
CD3E ProteinP07766 (Uniprot-TrEMBL)
CD3G ProteinP09693 (Uniprot-TrEMBL)
CD4 ProteinP01730 (Uniprot-TrEMBL)
CD45,CD148ComplexR-HSA-6785270 (Reactome)
CDC34 ProteinP49427 (Uniprot-TrEMBL)
CHUK ProteinO15111 (Uniprot-TrEMBL)
CHUK:IKBKB:IKBKGComplexR-HSA-168113 (Reactome) Co-immunoprecipitation studies and size exclusion chromatography analysis indicate that the high molecular weight (around 700 to 900 kDa) IKK complex is composed of two kinase subunits (IKK1/CHUK/IKBKA and/or IKK2/IKBKB/IKKB) bound to a regulatory gamma subunit (IKBKG/NEMO) (Rothwarf DMet al. 1998; Krappmann D et al. 2000; Miller BS & Zandi E 2001). Variants of the IKK complex containing IKBKA or IKBKB homodimers associated with NEMO may also exist. Crystallographic and quantitative analyses of the binding interactions between N-terminal NEMO and C-terminal IKBKB fragments showed that IKBKB dimers would interact with NEMO dimers resulting in 2:2 stoichiometry (Rushe M et al. 2008). Chemical cross-linking and equilibrium sedimentation analyses of IKBKG (NEMO) suggest a tetrameric oligomerization (dimers of dimers) (Tegethoff S et al. 2003). The tetrameric NEMO could sequester four kinase molecules, yielding an 2xIKBKA:2xIKBKB:4xNEMO stoichiometry (Tegethoff S et al. 2003). The above data suggest that the core IKK complex consists of an IKBKA:IKBKB heterodimer associated with an IKBKG dimer or higher oligomeric assemblies. However, the exact stoichiometry of the IKK complex remains unclear.
CSK ProteinP41240 (Uniprot-TrEMBL)
CSKProteinP41240 (Uniprot-TrEMBL)
CUL1 ProteinQ13616 (Uniprot-TrEMBL)
Csk:p-PAGComplexR-HSA-202297 (Reactome)
DAGs MetaboliteCHEBI:18035 (ChEBI)
DAGsMetaboliteCHEBI:18035 (ChEBI)
ENAH ProteinQ8N8S7 (Uniprot-TrEMBL)
EVL ProteinQ9UI08 (Uniprot-TrEMBL)
Ena/VASP proteinsComplexR-HSA-430213 (Reactome)
FBXW11 ProteinQ9UKB1 (Uniprot-TrEMBL)
FYB ProteinO15117 (Uniprot-TrEMBL)
FYBProteinO15117 (Uniprot-TrEMBL)
GADS:p-5Y-LATComplexR-HSA-202177 (Reactome)
GRAP2 ProteinO75791 (Uniprot-TrEMBL)
GRAP2ProteinO75791 (Uniprot-TrEMBL)
H2OMetaboliteCHEBI:15377 (ChEBI)
HLA class II histocompatibility antigen, DP ProteinP04440 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DP alpha chain precursor ProteinP20036 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DQ ProteinP01906 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DQ ProteinP01909 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DQ ProteinP01920 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DQ beta 2 chain ProteinP05538 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DQB1*0602 beta chain precursor ProteinP01920 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DR alpha chain precursor ProteinP01903 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DR beta 4 chain ProteinP13762 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DR beta 5 chain ProteinQ30154 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DR-1 beta chain precursor ProteinP01912 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-1 beta chain ProteinP04229 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-10 beta chain ProteinQ30167 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-11 beta chain ProteinP20039 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-12 beta chain ProteinQ95IE3 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-13 beta chain ProteinQ5Y7A7 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-14 beta chain ProteinQ9GIY3 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-15 beta chain ProteinP01911 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-16 beta chain ProteinQ29974 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-4 beta chain ProteinP13760 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-7 beta chain ProteinP13761 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-8 beta chain ProteinQ30134 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB1-9 beta chain precursor ProteinQ9TQE0 (Uniprot-TrEMBL)
HLA class II histocompatibility antigen, DRB3-1 beta chain precursor ProteinP79483 (Uniprot-TrEMBL)
I(1,4,5)P3MetaboliteCHEBI:16595 (ChEBI)
IKBKB ProteinO14920 (Uniprot-TrEMBL)
IKBKG ProteinQ9Y6K9 (Uniprot-TrEMBL)
INPP5DProteinQ92835 (Uniprot-TrEMBL)
ITK ProteinQ08881 (Uniprot-TrEMBL)
ITK:p-Y113,128,145-SLP-76:GADS:LATComplexR-HSA-202359 (Reactome)
ITKProteinQ08881 (Uniprot-TrEMBL)
IkB(alpha):NF-kB complexComplexR-HSA-193938 (Reactome)
K48-UbComplexR-HSA-912722 (Reactome) The most studied polyubiquitin chains - lysine48-linked - target proteins for destruction
K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complexComplexR-HSA-5607697 (Reactome)
K48PolyUb-K21,22-p-S32,S36-IkBA ProteinP25963 (Uniprot-TrEMBL)
K63polyUb-NEMO ProteinQ9Y6K9 (Uniprot-TrEMBL)
K63polyUb-TRAF6 ProteinQ9Y4K3 (Uniprot-TrEMBL)
K63polyUbR-HSA-450152 (Reactome)
LATProteinO43561 (Uniprot-TrEMBL)
LCK ProteinP06239 (Uniprot-TrEMBL)
LCP2 ProteinQ13094 (Uniprot-TrEMBL)
LCP2ProteinQ13094 (Uniprot-TrEMBL)
MALT1 ProteinQ9UDY8 (Uniprot-TrEMBL)
MALT1 trimer bound

to Bcl10 and CARMA1

trimer		ComplexR-HSA-202468 (Reactome)
MALT1 trimerComplexR-HSA-202487 (Reactome)
NCK1 ProteinP16333 (Uniprot-TrEMBL)
NCK1ProteinP16333 (Uniprot-TrEMBL)
NFKB1(1-433) ProteinP19838 (Uniprot-TrEMBL)
NFKB1(1-433):RELAComplexR-HSA-194043 (Reactome)
NFKB1(1-433):RELAComplexR-HSA-194047 (Reactome)
NFKBIA ProteinP25963 (Uniprot-TrEMBL)
PAK1 ProteinQ13153 (Uniprot-TrEMBL)
PAK1,2,3ComplexR-HSA-390765 (Reactome)
PAK2 ProteinQ13177 (Uniprot-TrEMBL)
PAK3 ProteinO75914 (Uniprot-TrEMBL)
PDK1:PIP2,PIP3ComplexR-HSA-202311 (Reactome)
PDPK1 ProteinO15530 (Uniprot-TrEMBL)
PDPK1ProteinO15530 (Uniprot-TrEMBL)
PI(3,4)P2 MetaboliteCHEBI:16152 (ChEBI)
PI(3,4)P2MetaboliteCHEBI:16152 (ChEBI)
PI(3,4,5)P3 MetaboliteCHEBI:16618 (ChEBI)
PI(3,4,5)P3MetaboliteCHEBI:16618 (ChEBI)
PI(4,5)P2 MetaboliteCHEBI:18348 (ChEBI)
PI(4,5)P2MetaboliteCHEBI:18348 (ChEBI)
PI3K bound to TRATComplexR-HSA-202283 (Reactome)
PI3KComplexR-HSA-74693 (Reactome)
PIK3CA ProteinP42336 (Uniprot-TrEMBL)
PIK3CB ProteinP42338 (Uniprot-TrEMBL)
PIK3R1 ProteinP27986 (Uniprot-TrEMBL)
PIK3R2 ProteinO00459 (Uniprot-TrEMBL)
PIP3 activates AKT signalingPathwayR-HSA-1257604 (Reactome) Signaling by AKT is one of the key outcomes of receptor tyrosine kinase (RTK) activation. AKT is activated by the cellular second messenger PIP3, a phospholipid that is generated by PI3K. In ustimulated cells, PI3K class IA enzymes reside in the cytosol as inactive heterodimers composed of p85 regulatory subunit and p110 catalytic subunit. In this complex, p85 stabilizes p110 while inhibiting its catalytic activity. Upon binding of extracellular ligands to RTKs, receptors dimerize and undergo autophosphorylation. The regulatory subunit of PI3K, p85, is recruited to phosphorylated cytosolic RTK domains either directly or indirectly, through adaptor proteins, leading to a conformational change in the PI3K IA heterodimer that relieves inhibition of the p110 catalytic subunit. Activated PI3K IA phosphorylates PIP2, converting it to PIP3; this reaction is negatively regulated by PTEN phosphatase. PIP3 recruits AKT to the plasma membrane, allowing TORC2 to phosphorylate a conserved serine residue of AKT. Phosphorylation of this serine induces a conformation change in AKT, exposing a conserved threonine residue that is then phosphorylated by PDPK1 (PDK1). Phosphorylation of both the threonine and the serine residue is required to fully activate AKT. The active AKT then dissociates from PIP3 and phosphorylates a number of cytosolic and nuclear proteins that play important roles in cell survival and metabolism. For a recent review of AKT signaling, please refer to Manning and Cantley, 2007.
PIP3, PI(3,4)P2ComplexR-ALL-202277 (Reactome)
PKC-theta (open): DAGComplexR-HSA-202187 (Reactome)
PLC-gamma1 bound to LAT or SLP-76ComplexR-HSA-202318 (Reactome)
PLCG1 ProteinP19174 (Uniprot-TrEMBL)
PLCG1:p-3Y-SLP-76:Gads:LATComplexR-HSA-202279 (Reactome)
PLCG1:p-5Y-LATComplexR-HSA-202240 (Reactome)
PLCG1ProteinP19174 (Uniprot-TrEMBL)
PRKCQ ProteinQ04759 (Uniprot-TrEMBL)
PRKQC closed conformationProteinQ04759 (Uniprot-TrEMBL)
PSMA1 ProteinP25786 (Uniprot-TrEMBL)
PSMA2 ProteinP25787 (Uniprot-TrEMBL)
PSMA3 ProteinP25788 (Uniprot-TrEMBL)
PSMA4 ProteinP25789 (Uniprot-TrEMBL)
PSMA5 ProteinP28066 (Uniprot-TrEMBL)
PSMA6 ProteinP60900 (Uniprot-TrEMBL)
PSMA7 ProteinO14818 (Uniprot-TrEMBL)
PSMA8 ProteinQ8TAA3 (Uniprot-TrEMBL)
PSMB1 ProteinP20618 (Uniprot-TrEMBL)
PSMB10 ProteinP40306 (Uniprot-TrEMBL)
PSMB11 ProteinA5LHX3 (Uniprot-TrEMBL)
PSMB2 ProteinP49721 (Uniprot-TrEMBL)
PSMB3 ProteinP49720 (Uniprot-TrEMBL)
PSMB4 ProteinP28070 (Uniprot-TrEMBL)
PSMB5 ProteinP28074 (Uniprot-TrEMBL)
PSMB6 ProteinP28072 (Uniprot-TrEMBL)
PSMB7 ProteinQ99436 (Uniprot-TrEMBL)
PSMB8 ProteinP28062 (Uniprot-TrEMBL)
PSMB9 ProteinP28065 (Uniprot-TrEMBL)
PSMC1 ProteinP62191 (Uniprot-TrEMBL)
PSMC2 ProteinP35998 (Uniprot-TrEMBL)
PSMC3 ProteinP17980 (Uniprot-TrEMBL)
PSMC4 ProteinP43686 (Uniprot-TrEMBL)
PSMC5 ProteinP62195 (Uniprot-TrEMBL)
PSMC6 ProteinP62333 (Uniprot-TrEMBL)
PSMD1 ProteinQ99460 (Uniprot-TrEMBL)
PSMD10 ProteinO75832 (Uniprot-TrEMBL)
PSMD11 ProteinO00231 (Uniprot-TrEMBL)
PSMD12 ProteinO00232 (Uniprot-TrEMBL)
PSMD13 ProteinQ9UNM6 (Uniprot-TrEMBL)
PSMD14 ProteinO00487 (Uniprot-TrEMBL)
PSMD2 ProteinQ13200 (Uniprot-TrEMBL)
PSMD3 ProteinO43242 (Uniprot-TrEMBL)
PSMD4 ProteinP55036 (Uniprot-TrEMBL)
PSMD5 ProteinQ16401 (Uniprot-TrEMBL)
PSMD6 ProteinQ15008 (Uniprot-TrEMBL)
PSMD7 ProteinP51665 (Uniprot-TrEMBL)
PSMD8 ProteinP48556 (Uniprot-TrEMBL)
PSMD9 ProteinO00233 (Uniprot-TrEMBL)
PSME1 ProteinQ06323 (Uniprot-TrEMBL)
PSME2 ProteinQ9UL46 (Uniprot-TrEMBL)
PSME3 ProteinP61289 (Uniprot-TrEMBL)
PSME4 ProteinQ14997 (Uniprot-TrEMBL)
PSMF1 ProteinQ92530 (Uniprot-TrEMBL)
PTENProteinP60484 (Uniprot-TrEMBL)
PTPN22 ProteinQ9Y2R2 (Uniprot-TrEMBL)
PTPN22:CSKComplexR-HSA-8855376 (Reactome)
PTPN22ProteinQ9Y2R2 (Uniprot-TrEMBL)
PTPRC ProteinP08575 (Uniprot-TrEMBL)
PTPRJ ProteinQ12913 (Uniprot-TrEMBL)
Phosphorylated

PLC-gamma1 bound to

LAT or SLP-76		ComplexR-HSA-202193 (Reactome)
Phosphorylated Bcl10

bound to CARMA1 and

RIP2		ComplexR-HSA-202480 (Reactome) Bcl10 interacts with the oligomerized CARMA1 and this is mediated by the CARD-CARD domainn interaction.
PiMetaboliteCHEBI:43474 (ChEBI)
RELA ProteinQ04206 (Uniprot-TrEMBL)
RIPK2ProteinO43353 (Uniprot-TrEMBL)
SCF-beta-TRCPComplexR-HSA-5607687 (Reactome)
SHFM1 ProteinP60896 (Uniprot-TrEMBL)
SKP1 ProteinP63208 (Uniprot-TrEMBL)
SLP-76 bound to Gads:LATComplexR-HSA-202151 (Reactome)
T-cell receptor alpha chain V region PY14 precursor ProteinP01737 (Uniprot-TrEMBL)
TAB2 ProteinQ9NYJ8 (Uniprot-TrEMBL)
TAB2/TAK1 complexComplexR-HSA-202504 (Reactome)
TAK1/TAB2 complex

bound to TRAF6/CBM

complex		ComplexR-HSA-202507 (Reactome)
TCRA ProteinP04437 (Uniprot-TrEMBL)
TCRB ProteinP04435 (Uniprot-TrEMBL)
TRAC ProteinP01848 (Uniprot-TrEMBL)
TRAF6 ProteinQ9Y4K3 (Uniprot-TrEMBL)
TRAF6 trimer bound to CBM complexComplexR-HSA-202471 (Reactome)
TRAF6ProteinQ9Y4K3 (Uniprot-TrEMBL)
TRAV19 ProteinA0A0A6YYK7 (Uniprot-TrEMBL)
TRBC1 ProteinP01850 (Uniprot-TrEMBL)
TRBV12-3 ProteinP01733 (Uniprot-TrEMBL)
UBE2D1 ProteinP51668 (Uniprot-TrEMBL)
UBE2D2 ProteinP62837 (Uniprot-TrEMBL)
UBE2D2,UBE2D1,(CDC34)ComplexR-HSA-5607669 (Reactome)
UBE2N ProteinP61088 (Uniprot-TrEMBL)
UBE2N:UBE2V1ComplexR-HSA-202463 (Reactome)
UBE2V1 ProteinQ13404 (Uniprot-TrEMBL)
Ub-124-UBB(77-152) ProteinP0CG47 (Uniprot-TrEMBL)
Ub-124-UBC(77-152) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-200-UBB(153-228) ProteinP0CG47 (Uniprot-TrEMBL)
Ub-200-UBC(153-228) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-276-UBC(229-304) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-352-UBC(305-380) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-428-UBC(381-456) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-48-RPS27A(1-76) ProteinP62979 (Uniprot-TrEMBL)
Ub-48-UBA52(1-76) ProteinP62987 (Uniprot-TrEMBL)
Ub-48-UBB(1-76) ProteinP0CG47 (Uniprot-TrEMBL)
Ub-48-UBC(1-76) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-504-UBC(457-532) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-580-UBC(533-608) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-656-UBC(609-684) ProteinP0CG48 (Uniprot-TrEMBL)
Ub-TRAF6 trimer

bound to CBM

complex		ComplexR-HSA-202456 (Reactome)
VASP ProteinP50552 (Uniprot-TrEMBL)
WAS ProteinP42768 (Uniprot-TrEMBL)
WASProteinP42768 (Uniprot-TrEMBL)
ZAP-70 and ITK tyrosine kinasesComplexR-HSA-202282 (Reactome)
ZAP-70 bound to

phosphorylated ITAM

motifs		ComplexR-HSA-202330 (Reactome)
ZAP70 ProteinP43403 (Uniprot-TrEMBL)
ZAP70ProteinP43403 (Uniprot-TrEMBL)
p-4Y-PLCG1 ProteinP19174 (Uniprot-TrEMBL)
p-5Y-LAT ProteinO43561 (Uniprot-TrEMBL)
p-5Y-LATProteinO43561 (Uniprot-TrEMBL)
p-6Y-CD247 ProteinP20963-1 (Uniprot-TrEMBL)
p-BCL10 ProteinO95999 (Uniprot-TrEMBL)
p-BCL10ProteinO95999 (Uniprot-TrEMBL)
p-MAP3K7 ProteinO43318 (Uniprot-TrEMBL)
p-PLCGComplexR-HSA-2029095 (Reactome)
p-S177,S181-IKBKB ProteinO14920 (Uniprot-TrEMBL)
p-S177,S181-IKKB:IKKA:NEMOComplexR-HSA-202513 (Reactome)
p-S177,S181-IKKB:IKKA:pUb-NEMOComplexR-HSA-202562 (Reactome)
p-S32,36-IkB-alpha:NF-kB complexComplexR-HSA-5607671 (Reactome)
p-S32,S36-NFKBIA ProteinP25963 (Uniprot-TrEMBL)
p-S552-CARD11 ProteinQ9BXL7 (Uniprot-TrEMBL)
p-S552-CARD11ProteinQ9BXL7 (Uniprot-TrEMBL)
p-SLP-76:ADAP:Ena/VASPComplexR-HSA-430206 (Reactome)
p-SLP-76:ADAPComplexR-HSA-430124 (Reactome)
p-SLP-76:NCK1:WASPComplexR-HSA-430186 (Reactome)
p-SLP-76:NCK1ComplexR-HSA-430188 (Reactome)
p-SLP-76:NCK:PAKComplexR-HSA-430189 (Reactome)
p-T184,T187-MAP3K7 ProteinO43318 (Uniprot-TrEMBL)
p-Y113,128,145-LCP2 ProteinQ13094 (Uniprot-TrEMBL)
p-Y113,128,145-LCP2ProteinQ13094 (Uniprot-TrEMBL)
p-Y113,128,145-SLP-76:GADS:LATComplexR-HSA-202162 (Reactome)
p-Y149,Y160-CD3D ProteinP04234 (Uniprot-TrEMBL)
p-Y160,Y171-CD3G ProteinP09693 (Uniprot-TrEMBL)
p-Y188,Y199-CD3E ProteinP07766 (Uniprot-TrEMBL)
p-Y315,Y493-ZAP70 ProteinP43403 (Uniprot-TrEMBL)
p-Y317-PAG1 ProteinQ9NWQ8 (Uniprot-TrEMBL)
p-Y317-PAG1ProteinQ9NWQ8 (Uniprot-TrEMBL)
p-Y394-LCK ProteinP06239 (Uniprot-TrEMBL)
p-Y493-ZAP70 ProteinP43403 (Uniprot-TrEMBL)
p-Y505-LCK ProteinP06239 (Uniprot-TrEMBL)
p-Y63,Y79,Y110-TRAT1 ProteinQ6PIZ9 (Uniprot-TrEMBL)
p-Y63,Y79,Y110-TRAT1ProteinQ6PIZ9 (Uniprot-TrEMBL)
p-Y753,Y759,Y1217-PLCG2 ProteinP16885 (Uniprot-TrEMBL)
p-Y771,Y783,Y1254-PLCG1 ProteinP19174 (Uniprot-TrEMBL)
p-Y771,Y783,Y1254-PLCG1ProteinP19174 (Uniprot-TrEMBL)
p-Y90,T538,S676,S695-PRKCQ ProteinQ04759 (Uniprot-TrEMBL)
p-Y90-PKC-theta:DAGComplexR-HSA-202300 (Reactome)
p-Y90-PRKCQ ProteinQ04759 (Uniprot-TrEMBL)
phospho tyrosine ZAP-70ComplexR-HSA-202345 (Reactome)
phosphorylated

PLC-gamma1 bound to

LAT		ComplexR-HSA-202310 (Reactome)
phosphorylated

PLC-gamma1 bound to

SLP-76		ComplexR-HSA-202302 (Reactome)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
26S proteasomemim-catalysisR-HSA-5607724 (Reactome)
ADPArrowR-HSA-202165 (Reactome)
ADPArrowR-HSA-202168 (Reactome)
ADPArrowR-HSA-202174 (Reactome)
ADPArrowR-HSA-202216 (Reactome)
ADPArrowR-HSA-202222 (Reactome)
ADPArrowR-HSA-202233 (Reactome)
ADPArrowR-HSA-202245 (Reactome)
ADPArrowR-HSA-202248 (Reactome)
ADPArrowR-HSA-202291 (Reactome)
ADPArrowR-HSA-202307 (Reactome)
ADPArrowR-HSA-202365 (Reactome)
ADPArrowR-HSA-202437 (Reactome)
ADPArrowR-HSA-202459 (Reactome)
ADPArrowR-HSA-202500 (Reactome)
ADPArrowR-HSA-202510 (Reactome)
ADPArrowR-HSA-202541 (Reactome)
ATPR-HSA-202165 (Reactome)
ATPR-HSA-202168 (Reactome)
ATPR-HSA-202174 (Reactome)
ATPR-HSA-202216 (Reactome)
ATPR-HSA-202222 (Reactome)
ATPR-HSA-202233 (Reactome)
ATPR-HSA-202245 (Reactome)
ATPR-HSA-202248 (Reactome)
ATPR-HSA-202291 (Reactome)
ATPR-HSA-202307 (Reactome)
ATPR-HSA-202365 (Reactome)
ATPR-HSA-202437 (Reactome)
ATPR-HSA-202459 (Reactome)
ATPR-HSA-202500 (Reactome)
ATPR-HSA-202510 (Reactome)
ATPR-HSA-202541 (Reactome)
Activated CARMA1ArrowR-HSA-202437 (Reactome)
Activated CARMA1R-HSA-202443 (Reactome)
Activated PLC gamma1 bound to PIP2ArrowR-HSA-202354 (Reactome)
Activated ZAP-70ArrowR-HSA-202174 (Reactome)
Activated ZAP-70mim-catalysisR-HSA-202216 (Reactome)
Activated ZAP-70mim-catalysisR-HSA-202245 (Reactome)
Active PKC theta bound to DAGArrowR-HSA-202222 (Reactome)
Active PKC theta bound to DAGmim-catalysisR-HSA-202437 (Reactome)
Antigen-bearing

MHC Class II

TCR

complex:CD4:p-Lck(Y505)		ArrowR-HSA-202233 (Reactome)
Antigen-bearing

MHC Class II

TCR

complex:CD4:p-Lck(Y505)		R-HSA-202214 (Reactome)
Antigen-bearing MHC

Class II  : TCR

complex:CD4:Lck		ArrowR-HSA-202214 (Reactome)
Antigen-bearing MHC

Class II  : TCR

complex:CD4:Lck		ArrowR-HSA-8852200 (Reactome)
Antigen-bearing MHC

Class II  : TCR

complex:CD4:Lck		R-HSA-202233 (Reactome)
Antigen-bearing MHC

Class II  : TCR

complex:CD4:Lck		R-HSA-202291 (Reactome)
Antigen-bearing MHC

Class II  : TCR

complex:CD4:Lck		mim-catalysisR-HSA-202291 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		ArrowR-HSA-202291 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		R-HSA-202165 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		R-HSA-8852200 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		mim-catalysisR-HSA-202165 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		mim-catalysisR-HSA-202168 (Reactome)
Antigen-bearing MHC

Class II :TCR complex:CD4: Lck phosphorylated at

Tyr394		mim-catalysisR-HSA-202307 (Reactome)
Antigen-bearing MHC

Class II: TCR with phosphorylated

ITAMs:CD4		ArrowR-HSA-202165 (Reactome)
Antigen-bearing MHC

Class II: TCR with phosphorylated

ITAMs:CD4		R-HSA-202344 (Reactome)
BCL10R-HSA-202466 (Reactome)
Bcl10 bound to CARMA1ArrowR-HSA-202466 (Reactome)
Bcl10 bound to CARMA1R-HSA-202459 (Reactome)
Bcl10 trimer bound to CARMA1 trimerArrowR-HSA-202489 (Reactome)
Bcl10 trimer bound to CARMA1 trimerR-HSA-202478 (Reactome)
CARD11R-HSA-202394 (Reactome)
CARMA1 bound to PDK1ArrowR-HSA-202394 (Reactome)
CARMA1 bound to PDK1R-HSA-202437 (Reactome)
CARMA1 trimerArrowR-HSA-202443 (Reactome)
CARMA1 trimerR-HSA-202466 (Reactome)
CD101TBarR-HSA-202248 (Reactome)
CD45,CD148TBarR-HSA-202233 (Reactome)
CD45,CD148mim-catalysisR-HSA-202214 (Reactome)
CHUK:IKBKB:IKBKGR-HSA-202500 (Reactome)
CSKArrowR-HSA-8855375 (Reactome)
CSKR-HSA-203774 (Reactome)
Csk:p-PAGArrowR-HSA-203774 (Reactome)
Csk:p-PAGmim-catalysisR-HSA-202233 (Reactome)
DAGsArrowR-HSA-202407 (Reactome)
DAGsR-HSA-202328 (Reactome)
Ena/VASP proteinsR-HSA-430201 (Reactome)
FYBR-HSA-430135 (Reactome)
GADS:p-5Y-LATArrowR-HSA-202325 (Reactome)
GADS:p-5Y-LATR-HSA-202241 (Reactome)
GRAP2R-HSA-202325 (Reactome)
H2OR-HSA-199456 (Reactome)
H2OR-HSA-202214 (Reactome)
H2OR-HSA-202237 (Reactome)
H2OR-HSA-202407 (Reactome)
H2OR-HSA-8852200 (Reactome)
H2OR-HSA-8855381 (Reactome)
I(1,4,5)P3ArrowR-HSA-202407 (Reactome)
INPP5Dmim-catalysisR-HSA-202237 (Reactome)
ITK:p-Y113,128,145-SLP-76:GADS:LATArrowR-HSA-202375 (Reactome)
ITKR-HSA-202375 (Reactome)
IkB(alpha):NF-kB complexR-HSA-202541 (Reactome)
K48-UbR-HSA-5607728 (Reactome)
K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complexArrowR-HSA-5607728 (Reactome)
K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complexR-HSA-5607724 (Reactome)
K63polyUbR-HSA-202453 (Reactome)
K63polyUbR-HSA-202534 (Reactome)
LATR-HSA-202245 (Reactome)
LCP2R-HSA-202241 (Reactome)
MALT1 trimer bound

to Bcl10 and CARMA1

trimer		ArrowR-HSA-202478 (Reactome)
MALT1 trimer bound

to Bcl10 and CARMA1

trimer		R-HSA-202472 (Reactome)
MALT1 trimerR-HSA-202478 (Reactome)
NCK1R-HSA-430190 (Reactome)
NFKB1(1-433):RELAArrowR-HSA-2730894 (Reactome)
NFKB1(1-433):RELAArrowR-HSA-5607724 (Reactome)
NFKB1(1-433):RELAR-HSA-2730894 (Reactome)
PAK1,2,3R-HSA-430183 (Reactome)
PDK1:PIP2,PIP3ArrowR-HSA-202164 (Reactome)
PDK1:PIP2,PIP3R-HSA-202394 (Reactome)
PDK1:PIP2,PIP3mim-catalysisR-HSA-202222 (Reactome)
PDPK1R-HSA-202164 (Reactome)
PI(3,4)P2ArrowR-HSA-202237 (Reactome)
PI(3,4,5)P3ArrowR-HSA-202365 (Reactome)
PI(3,4,5)P3R-HSA-199456 (Reactome)
PI(3,4,5)P3R-HSA-202237 (Reactome)
PI(4,5)P2ArrowR-HSA-199456 (Reactome)
PI(4,5)P2R-HSA-202354 (Reactome)
PI(4,5)P2R-HSA-202365 (Reactome)
PI(4,5)P2R-HSA-202407 (Reactome)
PI3K bound to TRATArrowR-HSA-202203 (Reactome)
PI3K bound to TRATmim-catalysisR-HSA-202365 (Reactome)
PI3KR-HSA-202203 (Reactome)
PIP3, PI(3,4)P2R-HSA-202164 (Reactome)
PKC-theta (open): DAGArrowR-HSA-202328 (Reactome)
PKC-theta (open): DAGR-HSA-202307 (Reactome)
PLC-gamma1 bound to LAT or SLP-76R-HSA-202248 (Reactome)
PLCG1:p-3Y-SLP-76:Gads:LATArrowR-HSA-202331 (Reactome)
PLCG1:p-5Y-LATArrowR-HSA-202212 (Reactome)
PLCG1R-HSA-202212 (Reactome)
PLCG1R-HSA-202331 (Reactome)
PRKQC closed conformationR-HSA-202328 (Reactome)
PTENmim-catalysisR-HSA-199456 (Reactome)
PTPN22:CSKR-HSA-8855375 (Reactome)
PTPN22ArrowR-HSA-8855375 (Reactome)
PTPN22mim-catalysisR-HSA-8852200 (Reactome)
PTPN22mim-catalysisR-HSA-8855381 (Reactome)
Phosphorylated

PLC-gamma1 bound to

LAT or SLP-76		ArrowR-HSA-202248 (Reactome)
Phosphorylated Bcl10

bound to CARMA1 and

RIP2		ArrowR-HSA-202459 (Reactome)
Phosphorylated Bcl10

bound to CARMA1 and

RIP2		R-HSA-202489 (Reactome)
PiArrowR-HSA-199456 (Reactome)
PiArrowR-HSA-202214 (Reactome)
PiArrowR-HSA-202237 (Reactome)
PiArrowR-HSA-8852200 (Reactome)
PiArrowR-HSA-8855381 (Reactome)
R-HSA-199456 (Reactome) At the plasma membrane, phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase aka phosphatase and tensin homolog (PTEN) dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) (Maehama & Dixon 1998, Myers et al. 1998, Das et al. 2003). The PI3K network is negatively regulated by phospholipid phosphatases that dephosphorylate PIP3, thus hampering AKT activation (Myers et al. 1998). The tumour suppressor PTEN is the primary phospholipid phosphatase.
Early studies indicated that magnesium ion, Mg2+, was needed for the catalytic activity of PTEN isolated from bovine thymus (Kabuyama et al. 1996). Subsequent studies have shown that PTEN was catalytically active in buffers free of magnesium and magnesium was not detected as part of the PTEN crystal (Lee et al. 1999).
R-HSA-202164 (Reactome) PI3K activation results in recruitment of the serine/threonine kinase PDK1, (3-phosphoinositide-dependent kinase 1) to the plasma membrane where PDK1 subsequently phosphorylates and activates AKT. PDK1 with its PH domain binds to either PIP3 or PIP2 and is translocated to the plasma membrane. PDK1 seems to exist in an active, phosphorylated configuration under basal conditions (Vanhaesebroeck & Alessi 2000).
R-HSA-202165 (Reactome) The autophosphorylated, active Lck is now proximally positioned to phosphorylate specific tyrosine residues within ITAMs (immunoreceptor tyrosine-based activation motifs) located within the CD3 and the TCR zeta signaling chains of the TCR. ITAMs consist of evolutionarily conserved amino-acid sequence motifs of D/ExYxxLx(6-8)YxxL. Both the tyrosine residues in the motif are phosphorylated by Lck and the TCR complex include 10 ITAMs with one ITAM in each of the CD3 chains including the three tandem ITAMs in each zeta chains.
R-HSA-202168 (Reactome) In ZAP-70 there are multiple phosphorylation sites (Y292, Y315, Y319, Y492, Y493) which have both positive and negative regulatory effect on its catalytic activity. Tyrosine 493 is a conserved regulatory site found within the activation loop of the kinase domain. This site has shown to be a positive regulatory site required for ZAP-70 kinase activity and is phosphorylated by Lck. This phosphorylation contribute to the active conformation of the catalytic domain.
R-HSA-202174 (Reactome) Later ZAP-70 undergoes trans-autophosphorylation at Y315 and Y319. These sites appear to be positive regulatory sites. ZAP-70 achieve its full activation after the trans-autophosphorylation. Activated ZAP-70 phosphorylates T-cell-specific adaptors, such as LAT and SLP-76 leading to the recruitment and activation of other kinase families and enzymes, resulting in secondary messenger generation and culminating in T cell activation.
R-HSA-202203 (Reactome) In response to the TCR stimulation, phsophoinositides are phosphorylated on the 3-position of the inositol ring by PI3K to generate lipid second messengers that serve as membrane docking sites for a variety of downstream effector proteins such as PDK1 and PKB. PI3K is a heterodimer comprising a regulatory subunit p85 and a catalytic subunit p110 which associate constitutively and are activated upon interaction with tyrosine-phosphorylated proteins at the plasma membrane. The p85 subunit contains two SH2 domains and an SH3 domain. p85 subunit is involved in interaction with two phsophotyrosine residues of the adaptor protein TRIM with its two SH2 domains. This interaction is important in recruiting the p110 subunit to the plasma membrane and activate the p110 kinase activity, which is normally inhibited in the p85-p110 complex.
R-HSA-202212 (Reactome) PLC-gamma1 interacts with its SH2 domain to the pY132 residue of LAT.
R-HSA-202214 (Reactome) TCR stimulation induce the transient dephosphorylation of PAG thereby release the Csk from its plasma membrane anchor. The release of Csk from its proximity with Lck may serve to facilitate the activation of Lck.Protein tyrosine phosphtase CD45 (PTPRC) and CD148 (PTPRJ) have dual function in TCR signalling. They act both in activation as well as inactivation of Src family kinases (SFKs) which are involved in the initiation of TCR signal transduction (Stepanek et al. 2011). The activatory role is to dephosphorylate an inhibitory site tyrosine 505 (Y505) at the C-terminal end of Lck, which is needed to enable Lck to an open conformation and expose the activation loop (A-loop) containing the activating tyrosine 394 (Y394) (Xu et al. 1993. McNeill et al. 2007, Zikherman et al. 2010, Stepanek et al. 2011, Salmond et al. 2009).
R-HSA-202216 (Reactome) Once SLP-76 is recruited to Gads its rapidly phosphorylated on the tyrosine residues in the N-terminal acidic domain. This domain contains three tyrosine phosphorylation sites, Y113, Y128 and Y145. These tyrosine residues are phosphorylated by tyrosine kinase ZAP-70 and these phosphorylated tyrosine residues provide the binding site for the SH2 domains of the incoming signaling proteins like Vav, Itk and PLC-gamma1.
R-HSA-202222 (Reactome) Raft localized PKC theta is further phosphorylated and activated by PDK1. The threonine residue (T538) in the kinase domain is the potential target of PDK1. Phosphorylation of this site is critical for the PKC theta kinase activity, and its ability to activate NF-kB pathway. PKC theta is later trans-autophopshorylated on putative phosphorylation sites (S676, S695) for the fine-tuning of its kinase activity.
R-HSA-202233 (Reactome) Lck is a member of the Src family tyrosine kinases and these members have the following domains in common: N-terminal Myristoylation site for saturated fatty acid addition, a unique region, a Src-homology 3 (SH3) domain, an SH2 domain, a tyrosine kinase domain (SH1), and a C-terminal negative regulatory domain. Myristoylation engenders Lck with the ability to attach to cellular membranes. This interaction is mediated by both myristic acid and palmitic acid that are bound to the amino terminal glycine and Cys-3 and/or Cys-5.

The unique region of Lck is thought to be involved in the interaction with the cytoplasmic tails of coreceptors CD4 and CD8. The Lck/CD4 interaction require conserved cysteine motifs: a CxCP motif in CD4 and a CxxC motif in the Lck unique domain. The SH3 and SH2 domains of Lck are involved in intramolecular and intermolecular regulation by mediating protein-protein interactions via poly-proline and phosphotyrosine-specific interactions, respectively.

Lck adopts specific conformation that largely dictate its level of activity. The C-ter tail has an autoinhibitory phosphorylation site (tyr 505). When the Y505 is phosphorylated, Lck adopts a closed conformation, where the pY505 residue creates an intramolecular binding motif for the SH2 domain, effectively inactivating the kinase domain. The inactivating phosphorylation on Y505 is carried out by the Src-specific kinase Csk.
R-HSA-202237 (Reactome) After the generation of PIP3 by PI3K, a part of it is further dephosphorylated to generate other forms of PI which are also involved in signaling. Two major routes for the degradation of PIP3 exists: dephosphorylation by the haematopoietic-specific SH2 domain-containing inositol 5' phosphatase SHIP-1 and dephosphorylation by the 3' phosphoinositide phosphatase PTEN.
SHIP-1 appears to set an activation threshold on T cell signaling. SHIP-1 phosphatase activity removes the 5' phosphate of PIP3 and generate phosphatidylinositol 3,4-bisphosphate. PI(3,4)P2 along with PIP3 preferentially binds to the PH domains of PKB and PDK1.
R-HSA-202241 (Reactome) SLP-76 is an adaptor protein that links proximal and distal T cell receptor signaling events through its function as a molecular scaffold in the assembly of multi molecular signaling complexes. SLP-76 consists of three domains that mediate interactions with many different signaling proteins: an N-terminal acidic domain containing three tyrosine phosphorylation sites, a large central proline-rich region, and a C-terminal SH2 domain. The function of SLP-76 is dependent on its association with Gads. SLP-76 constitutively binds through its 'RxxK' motif in the proline rich region to the SH3 domain of Gads upon TCR activation.
R-HSA-202245 (Reactome) The adaptor molecule LAT (Linker for the Activation of T cells) is a membrane protein that links the TCR signal to the cell activation. It has a total 10 (Y36, Y45, Y64, Y110, Y156, Y161, Y200, Y220, and Y255) conserved TBSMs (tyrosine based signaling motifs) in its cytoplasmic region. These tyrosine residues are phosphorylated by the activated ZAP-70 upon TCR/CD3 complex engagement. Phosphorylation of LAT creates binding sites for the Src homology 2 (SH2) domains of other proteins, including PLC-gamma1, Grb2 and Gads, and indirectly binds SOS, Vav, SLP-76, and Itk. The residues Y200, Y220 and Y255 are responsible for Grb2 binding, Y200 and Y220 but not Y255, are necessary for Gads binding and Y161 for the PLC-gamma1 binding (numbering based on Uniprot isoform 1).
R-HSA-202248 (Reactome) Three tyrosine residues at positions 771, 783 and 1254 in PLC-gamma1 have been identified as the sites of receptor tyrosine kinase phosphorylation. Of these Y783 and Y1254 are required for activation of PLC-gamma1. The phosphorylation of the tyrosine residues and the activation of PLC-gamma1 is mediated by both Syk tyrosine kinase ZAP-70 and Tec kinase ITK.
R-HSA-202291 (Reactome) The binding of CD4/CD8 to non-polymorphic regions of MHC brings Lck in to proximity with TCR subunits phosphorylation. Lck is further phosphorylated to promote the active conformation and to increase their catalytic activity. The C-term domain contain a regulatory activation loop, which is the site of activating Tyr 394 phosphorylation. This tyrosine is auto-phosphorylated to attain an active conformation on TCR stimulation. Now Lck through its kinase activity phosphorylates the ITAMs in TCR zeta and CD3 members.
R-HSA-202307 (Reactome) PKC theta localizes at the interface between T cells and antigen presenting cells. Upon the T cell activation and release of the second messengers Ca++ and DAG by PLC-gamma1, DAG binds to the C1 domain of the PKC theta thereby enhances the attachment to the plasma membrane. Upon membrane translocation, PKC theta is phosphorylated at tyrosine 90 in the C2 like domain. This phosphorylation is mediated by the tyrosine kinase Lck. These association and, most likely, other regulatory interactions, lead to a change in PKC theta conformation into an open, active state whereby it can now access its substrates and phosphorylate them.
R-HSA-202325 (Reactome) Gads is a member of the Grb2 family containing SH2 and SH3 domains with the arrangement SH3-SH2-SH3. Gads binds to the tyrosine phosphorylated residues Y171 and Y191 of LAT through its SH2 domain. It plays a critical role in signaling from the T cell receptor by promoting the formation of a complex between SLP-76 and LAT.
R-HSA-202328 (Reactome) DAG along with intracellular calcium signals cooperatively to activate PKCs, which then trigger other pathways such as the NF-kB pathway, ultimately leading to mast cell (MC) degranulation and cytokine production (Wu 2011). PKC theta is a member of the Ca++ independent and DAG dependent, novel PKC subfamily expressed mainly in T cells. It contains, N-term C2 like domain, a pseudosubstrate (PS), DAG binding (C1) domain and a C-term kinase domain. The PS sequence resembles an ideal substrate with the exception that it contains an alanine residue instead of a substrate serine residue, is bound to the kinase domain in the resting state. As a result, PKC theta is maintained in a closed inactive state, which is inaccessible to cellular substrates.
MCs express several Protein kinase C (PKC) isozymes and these kinases are involved in both the activation and termination of the degranulation process. PKC-delta is a negative regulator of FCERI mediated mast cell degranulation, whereas PKC-theta facilitates in degranulation (Leitges et al. 2002, Liu et al. 2001). In response to FCERI activation PKC-theta translocates to membrane by binding to DAG with its C1 domain. PKC-theta exists in two conformations closed/inactive and open/active state. In resting state, PKC-theta is autoinhibited where the pseudosubstrate sequence in the N-terminal regulatory region of PKC-theta forms intramolecular interaction with the substrate-binding region in the catalytic domain. This prevents the catalytic domain gaining access to substrates. The allosteric change of PKC-theta from closed to open state involves two important mechanisms: DAG binding to the C1 domains and autophosphorylation of T538 on the activation loop. Interaction with DAG induces conformational change resulting in the exposure of the activation loop of PKC-theta (Wang et al. 2012, Melowic et al. 2007).
R-HSA-202331 (Reactome) PLC-gamma1 plays an important role in transducing the external signal in to second messengers by hydrolysing PIP2. PLC-gamma1 contains an N-term PH domain, a catalytic domain 'X' followed by two SH2 domains and an SH3 domain, a C-term catalytic domain 'Y' and a C2 domain (Ca++ binding). PLC-gamma1 interacts with both SLP-76 aswell as LAT. It interacts with its SH3 domain to the proline rich sequence of SLP-76. This interaction aids in localizing PLC-gamma1 to the membrane. This recruitment of PLC-gamma1 to LAT and SLP-76 is essential for its TCR induced tyrosine phosphorylation and activation.
R-HSA-202344 (Reactome) Phosphorylation of the ITAMs by Lck is followed by the recruitment of the ZAP-70 a member of Syk family PTK, to the receptor complex. ZAP-70 is exclusively expressed in T cells and NK cells. The dually phosphorylated ITAMs provide a high-affinity docking site for the tandem SH2-domains of the ZAP-70. Once recruited, ZAP-70 is activated by phosphorylation and will be responsible for the phosphorylation of further downstream molecules. Due to the presence of 10 ITAMs in the TCR complex, up to 10 ZAP-70 molecules may cluster on the fully phosphorylated receptors.
R-HSA-202354 (Reactome) Activated PLA-gamma1 translocates to the plasmamembrane and interacts with the inositol ring of the membrane bound phosphatidylinositol 4,5-bisphosphate (PIP2) with its PH domain.
R-HSA-202365 (Reactome) PI3K enzyme bound to adaptor protein TRIM, uses phosphatidylinositol 4,5-bisphosphate (PIP2) as its substrate and phosphorylates it to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). This PIP3 acts as a membrane anchor for the downstream proteins like PDK1 and PKB.
R-HSA-202375 (Reactome) ITK is a member of the Tec protein tyrosine kinase family which forms a complex with SLP-76 after TCR activation. ITK has N-terminal pleckstrin homology (PH) domain, a Tec homology (TH) domain, a proline rich domain, a SH3 domain, an SH2 domain and a C-term kinase domain. The SH2 domain of ITK may interact with Y145 within the N-ter acidic domain of SLP-76 and the SH3 domain of the ITK binds the proline rich region of SLP-76. ITK plays an important role in phosphorylating and activating PLC-gamma-1, leading to the development of second-messenger molecules.
R-HSA-202394 (Reactome) CARMA1 and Bcl10 are the possible link between PKC theta and IKK activation. PDK1 is also required for PKC theta mediated activation of IKK. CARMA1 has a N-terminal CARD motif, a coiled coiled region, a linker region, and a MAGUK-typical PDZ, SH3 and a GUK domains. The linker region is proposed to contain a hinge region and a CARD binding domain. CARMA1 exists in an inactive conformation in which the linker region binds to and blocks the accessibility of the CARD motif. CARMA1 is recruited to the plasma membrane by binding to the 'PxxP' motif of membrane bound PDK1 with its SH3 domain.
R-HSA-202407 (Reactome) On recruitment to plasma membrane PLC-gamma1 then hydrolyses PIP2 producing two second messengers, diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 induces a transient increase in intracellular free Ca++, while DAG is a direct activator of protein kinase C (PKC theta). These process have been implicated in many cellular physiological functions like cell proliferation, cell growth and differentiation.
R-HSA-202437 (Reactome) Antigen receptor triggered PKC theta dependent linker phosphorylation of S552 residue is required to release this inhibition and expose the CARD motif for downstream Bcl10 recruitment. PDK1 and maybe other unknown adapter proteins bring PKC theta and CARMA1 into close proximity, facilitating PKC theta mediated CARMA1 phosphorylation and consequent activation.
R-HSA-202443 (Reactome) After the phosphorylation and activation CARMA1 undergoes oligomerization, likely through its CC domain. CARMA1 is thought to oligomerize first as a trimer which triggers downstream oligomerization cascade that is ultimately necessary for the subsequent activation of the IKK complex.
R-HSA-202453 (Reactome) TRAF6 possesses ubiquitin ligase activity and undergoes K-63-linked auto-ubiquitination after its oligomerization. In the first step, ubiquitin is activated by an E1 ubiquitin activating enzyme. The activated ubiquitin is transferred to a E2 conjugating enzyme (a heterodimer of proteins Ubc13 and Uev1A) forming the E2-Ub thioester. Finally, in the presence of ubiquitin-protein ligase E3 (TRAF6, a RING-domain E3), ubiquitin is attached to the target protein (TRAF6 on residue Lysine 124) through an isopeptide bond between the C-terminus of ubiquitin and the epsilon-amino group of a lysine residue in the target protein. In contrast to K-48-linked ubiquitination that leads to the proteosomal degradation of the target protein, K-63-linked polyubiquitin chains act as a scaffold to assemble protein kinase complexes and mediate their activation through proteosome-independent mechanisms. This K63 polyubiquitinated TRAF6 activates the TAK1 kinase complex.
R-HSA-202459 (Reactome) Upon interaction with CARMA1, Bcl10 undergoes phosphorylation and oligomerization. The oligomerized Bcl10 acts as a adaptor for the incoming MALT1 and TRAF6. Phosphorylation events of Bcl10 can both positively and negatively regulate the NF-kB pathway. Phosphorylation of Bcl10 that depends on the Ser/Thr kinase RIP2 and correlated with the physical association of Bcl10 with RIP2 has a activation effect on the NF-kB pathway. The target sites of RIP2-mediated phosphorylation has not yet been identified.
R-HSA-202466 (Reactome) Bcl10 is recruited to activated, oligomeric CARMA1 through a CARD-CARD interaction. Bcl10 is characterized by an N-terminal CARD motif and a C-terminal extension of ~130 amino acids rich in serine and threonine residues that serve as targets for multiple phosphorylation events.
R-HSA-202472 (Reactome) TRAF6, which plays central role in innate immune responses, is implicated as proximal downstream effector of MALT1. TRAF6 is a member of the TRAF proteins. It contains an N-term RING domain, followed by several Zn finger domains and C-term MATH domain. The MALT1 oligomers bind to TRAF6, induce TRAF6 oligomerization and thereby activate the ubiquitin ligase activity of TRAF6 to polyubiquitinate itself and NEMO.
R-HSA-202478 (Reactome) Oligomerized Bcl10 facilitates the association with MALT1 to form the CBM signalosome. MALT1 possesses one death domain (DD) and 2 immunoglobulin-like domains (Ig-like) in its N-terminal region and a caspase like domain (CLD) in its C-terminal region. The region between amino acids 107 and 119 of Bcl10 bind to the two Ig-like domains of MALT1. After binding to CARMA1 and Bcl10 complex, MALT1 also undergoes oligomerization. Only the oligomerized forms of Bcl10 and MALT1 are capable of activating IKK.
R-HSA-202489 (Reactome) Association with RIP2 and its phosphorylation allows subsequent trimerization of Bcl10.
R-HSA-202500 (Reactome) The IkB kinase (IKK) complex serves as the master regulator for the activation of NF-kB by various stimuli. It contains two catalytic subunits, IKK alpha and IKK beta, and a regulatory subunit, IKKgamma/NEMO. The activation of IKK complex is dependent on the phosphorylation of IKK alpha/beta at its activation loop and the K63-linked ubiquitination of NEMO. This basic trimolecular complex is referred to as the IKK complex.
IKK subunits have a N-term kinase domain a leucine zipper (LZ) motifs, a helix-loop-helix (HLH) and a C-ter NEMO binding domain (NBD). IKK catalytic subunits are dimerized through their LZ motifs. IKK beta is the major IKK catalytic subunit for NF-kB activation. Activated TAK1 phosphorylate IKK beta on serine residues (S177 and S181) in the activation loop and thus activate the IKK kinase activity, leading to the IkB alpha phosphorylation and NF-kB activation.
R-HSA-202510 (Reactome) Ubiquitinated TRAF6 recruits TAB2 and activates the TAB2-associated TAK1 kianse by promoting the autophosphorylation of TAK1. TAB2 contains an N-term pseudophosphatase domain, which is indispensable for TAK1 activation, and a C-term domain that binds to and activates TAK1. The activation of TAK1/TAB2 complex requires a ubiquitination reaction catalysed by E1, Ubc13/Uev1A (E2) and TRAF6 (E3). TAK1 undergoes autophosphorylation on residues T184 and T187 and gets activated. Activated TAK1 then phosphorylates and activates IKK beta.
R-HSA-202534 (Reactome) During the phosphorylation of the IKK beta, the regulatory subunit NEMO undergoes K-63-linked polyubiquitination. Ubiquitinated TRAF6 trimer, acts as a E3 ligase and induces this ubiquitination. The ubiquitin target sites in NEMO are not yet clearly identified. Studies of different NF-kB signaling pathways revealed several potential ubiquitination sites on NEMO (e.g., K285, K277, K309 and K399) (Fuminori et al. 2009).
R-HSA-202541 (Reactome) NF-kB is sequestered in the cytosol of unstimulated cells through the interactions with a class of inhibitor proteins, called IkBs, which mask the nuclear localization signal (NLS) of NF-kB and prevent its nuclear translocation. A key event in NF-kB activation involves phosphorylation of IkB (at sites equivalent to Ser32 and Ser36 of IkB-alpha or Ser19 and Ser22 of IkB-beta) by IKK. The phosphorylated IkB-alpha is recognized by the E3 ligase complex and targeted for ubiquitin-mediated proteasomal degradation, releasing the NF-kB dimer p50/p65 into the nucleus to turn on target genes. (Karin & Ben-Neriah 2000)
R-HSA-203774 (Reactome) Csk is a tyrosine kinase that phosphorylates the negative regulatory C-terminal tyrosine residue Y505 of Lck to maintain Lck in an inactive state. In resting T cells, Csk is targeted to lipid rafts through engagement of its SH2 domain with phosphotyrosine residue pY317 of PAG. PAG is expressed as a tyrosine phosphorylated protein in nonstimulated T-cells. This interaction of Csk and PAG allows activation of Csk and inhibition of Lck. Given that PAG-1 T cell knock out show a weak phenotype, some other protein may substitute in activating Csk.
R-HSA-213406 (Reactome) The activated PLC-gamma1 detaches from its substrate LAT and translocates to the membrane.
R-HSA-213407 (Reactome) The activated PLC-gamma1 detaches from its substrate SLP-76 and translocates to the membrane.
R-HSA-2730894 (Reactome) The released NF-kB transcription factor (p50/p65) with unmasked nuclear localization signal (NLS) moves in to the nucleus. Once in the nucleus, NF-kB binds DNA and regulate the expression of genes encoding cytokines, cytokine receptors, and apoptotic regulators.
R-HSA-430135 (Reactome) SLP-76 inducibly-associates with ADAP (also known as FYN-binding protein or SLAP-130) a hematopoietic-specific adapter protein. ADAP has been implicated in T cell migration and rearrangement of the actin cytoskeleton. In platelets, adhesion to fibrinogen stimulates the association of SLP-76 with ADAP and VASP (Obergfell et al. 2001). ADAP knockout mice exhibit mild thrombocytopenia (Kasirer-Friede et al. 2007).
R-HSA-430180 (Reactome) The second SH3 domain of NCK interacts with the carboxy-terminal SH3 domain of WASP. WASP family proteins bind the Arp2/3 complex, stimulating its ability to nucleate actin filaments and induce filament branching.
R-HSA-430183 (Reactome) NCK binds to PAK through its second SH3 domain. PAK interacts with NCK via the amino terminal SH3 binding domain. This interaction leads to the phosphorylation of NCK at multiple sites.
R-HSA-430190 (Reactome) SLP-76 interacts with the adaptor protein NCK1. This interaction involved the SH2 domain of NCK1, leaving 3 three SH3 domains free to interact with other proteins, notably PAK1, N-WASP and Sos.
R-HSA-430201 (Reactome) ADAP (FYB) is an adaptor protein containing multiple binding motifs including an enabled protein vasodilator-stimulated phosphoprotein homology domain 1 (EVH1)-binding domain. This domain binds Ena-VASP family proteins that regulate actin dynamics. The Ena-VASP family member EVL is found in regions of dynamic actin polymerization, such as F-actin rich patches and the distal tips of microspikes.
R-HSA-5607724 (Reactome) Following ubiquitination Ikappa B-alpha (IKBA) is rapidly degraded by 26S-proteasome, allowing NF-kB to translocate into the nucleus where it activates gene transcription (Spencer et al. 1999).
R-HSA-5607728 (Reactome) Two major signaling steps are required for the removal of IkappaB (IkB) alpha an inhibitor of NF-kB: activation of the IkB kinase (IKK) and degradation of the phosphorylated IkB alpha. IKK activation and IkB degradation involve different ubiquitination modes; the former is mediated by K63-ubiquitination and the later by K48-ubiquitination. Mutational analysis of IkB alpha has indicated that K21 and K22 are the primary sites for addition of multiubiquitination chains while K38 and K47 are the secondary sites. In a transesterification reaction the ubiquitin is transferred from the ubiquitin-activating enzyme (E1) to an E2 ubiquitin-conjugating enzyme, which may, in turn, transfer the ubiquitin to an E3 ubiquitin protein ligase. UBE2D2 (UBC4) or UBE2D1 (UBCH5) or CDC34 (UBC3) acts as the E2 and SCF (SKP1-CUL1-F-box)-beta-TRCP complex acts as the E3 ubiquitin ligase (Strack et al. 2000, Wu et al. 2010). beta-TRCP (beta-transducin repeats-containing protein) is the substrate recognition subunit for the SCF-beta-TRCP E3 ubiquitin ligase. beta-TRCP binds specifically to phosphorylated IkB alpha and recruits it to the SCF complex, allowing the associated E2, such as UBC4 and or UBCH5 to ubiquitinate Ikappa B alpha (Baldi et al. 1996, Rodriguez et al. 1996, Scherer et al. 1995, Alkalay et al. 1995).
R-HSA-8852200 (Reactome) Protein tyrosine phosphatase PTPN22 (LYP, PEP) (Cohen et al. 1999) dephosphorylates tyrosine residue Y394 of LCK, thus inactivating LCK and down-regulating TCR signaling (Wu et al. 2006, Vang et al. 2012).
R-HSA-8855375 (Reactome) In unstimulated T-lymphocytes, protein tyrosine phosphatase PTPN22 (LYP, PEP) is associated with CSK, which inhibits the catalytic activity of PTPN22. In response to TCR-stimulation, the complex of CSK and PTPN22 dissociates through an unknown mechanism, which allows PTPN22 to be recruited to lipid rafts. The PTPN22 variant PTPN22 R620W, the result of a SNP associated with autoimmune diseases, does not bind to CSK and is constitutively active (Vang et al. 2012).
R-HSA-8855381 (Reactome) Protein tyrosine phosphatase PTPN22 (LYP, PEP) dephosphorylates ZAP70 adaptor protein on tyrosine residue Y493, resulting in reduced activation of ZAP70. Dephosphorylation of ZAP70 contributes to PTPN22-mediated downregulation of TCR signaling (Wu et al. 2006).
RIPK2mim-catalysisR-HSA-202459 (Reactome)
SCF-beta-TRCPArrowR-HSA-5607728 (Reactome)
SCF-beta-TRCPR-HSA-5607728 (Reactome)
SCF-beta-TRCPmim-catalysisR-HSA-5607728 (Reactome)
SLP-76 bound to Gads:LATArrowR-HSA-202241 (Reactome)
SLP-76 bound to Gads:LATR-HSA-202216 (Reactome)
TAB2/TAK1 complexR-HSA-202510 (Reactome)
TAB2/TAK1 complexmim-catalysisR-HSA-202510 (Reactome)
TAK1/TAB2 complex

bound to TRAF6/CBM

complex		ArrowR-HSA-202510 (Reactome)
TAK1/TAB2 complex

bound to TRAF6/CBM

complex		mim-catalysisR-HSA-202500 (Reactome)
TRAF6 trimer bound to CBM complexArrowR-HSA-202472 (Reactome)
TRAF6 trimer bound to CBM complexR-HSA-202453 (Reactome)
TRAF6 trimer bound to CBM complexmim-catalysisR-HSA-202453 (Reactome)
TRAF6R-HSA-202472 (Reactome)
UBE2D2,UBE2D1,(CDC34)ArrowR-HSA-5607728 (Reactome)
UBE2D2,UBE2D1,(CDC34)R-HSA-5607728 (Reactome)
UBE2N:UBE2V1ArrowR-HSA-202453 (Reactome)
UBE2N:UBE2V1ArrowR-HSA-202534 (Reactome)
UBE2N:UBE2V1R-HSA-202453 (Reactome)
UBE2N:UBE2V1R-HSA-202534 (Reactome)
Ub-TRAF6 trimer

bound to CBM

complex		ArrowR-HSA-202453 (Reactome)
Ub-TRAF6 trimer

bound to CBM

complex		R-HSA-202510 (Reactome)
Ub-TRAF6 trimer

bound to CBM

complex		mim-catalysisR-HSA-202534 (Reactome)
WASR-HSA-430180 (Reactome)
ZAP-70 and ITK tyrosine kinasesmim-catalysisR-HSA-202248 (Reactome)
ZAP-70 bound to

phosphorylated ITAM

motifs		ArrowR-HSA-202344 (Reactome)
ZAP-70 bound to

phosphorylated ITAM

motifs		ArrowR-HSA-8855381 (Reactome)
ZAP-70 bound to

phosphorylated ITAM

motifs		R-HSA-202168 (Reactome)
ZAP70R-HSA-202344 (Reactome)
p-5Y-LATArrowR-HSA-202245 (Reactome)
p-5Y-LATArrowR-HSA-213406 (Reactome)
p-5Y-LATR-HSA-202212 (Reactome)
p-5Y-LATR-HSA-202325 (Reactome)
p-BCL10R-HSA-202489 (Reactome)
p-PLCGmim-catalysisR-HSA-202407 (Reactome)
p-S177,S181-IKKB:IKKA:NEMOArrowR-HSA-202500 (Reactome)
p-S177,S181-IKKB:IKKA:NEMOR-HSA-202534 (Reactome)
p-S177,S181-IKKB:IKKA:pUb-NEMOArrowR-HSA-202534 (Reactome)
p-S177,S181-IKKB:IKKA:pUb-NEMOmim-catalysisR-HSA-202541 (Reactome)
p-S32,36-IkB-alpha:NF-kB complexArrowR-HSA-202541 (Reactome)
p-S32,36-IkB-alpha:NF-kB complexR-HSA-5607728 (Reactome)
p-S552-CARD11R-HSA-202443 (Reactome)
p-SLP-76:ADAP:Ena/VASPArrowR-HSA-430201 (Reactome)
p-SLP-76:ADAPArrowR-HSA-430135 (Reactome)
p-SLP-76:ADAPR-HSA-430201 (Reactome)
p-SLP-76:NCK1:WASPArrowR-HSA-430180 (Reactome)
p-SLP-76:NCK1ArrowR-HSA-430190 (Reactome)
p-SLP-76:NCK1R-HSA-430180 (Reactome)
p-SLP-76:NCK1R-HSA-430183 (Reactome)
p-SLP-76:NCK:PAKArrowR-HSA-430183 (Reactome)
p-Y113,128,145-LCP2R-HSA-430135 (Reactome)
p-Y113,128,145-LCP2R-HSA-430190 (Reactome)
p-Y113,128,145-SLP-76:GADS:LATArrowR-HSA-202216 (Reactome)
p-Y113,128,145-SLP-76:GADS:LATArrowR-HSA-213407 (Reactome)
p-Y113,128,145-SLP-76:GADS:LATR-HSA-202331 (Reactome)
p-Y113,128,145-SLP-76:GADS:LATR-HSA-202375 (Reactome)
p-Y317-PAG1R-HSA-203774 (Reactome)
p-Y63,Y79,Y110-TRAT1R-HSA-202203 (Reactome)
p-Y771,Y783,Y1254-PLCG1ArrowR-HSA-213406 (Reactome)
p-Y771,Y783,Y1254-PLCG1ArrowR-HSA-213407 (Reactome)
p-Y771,Y783,Y1254-PLCG1R-HSA-202354 (Reactome)
p-Y90-PKC-theta:DAGArrowR-HSA-202307 (Reactome)
p-Y90-PKC-theta:DAGR-HSA-202222 (Reactome)
phospho tyrosine ZAP-70ArrowR-HSA-202168 (Reactome)
phospho tyrosine ZAP-70R-HSA-202174 (Reactome)
phospho tyrosine ZAP-70R-HSA-8855381 (Reactome)
phospho tyrosine ZAP-70mim-catalysisR-HSA-202174 (Reactome)
phosphorylated

PLC-gamma1 bound to

LAT		R-HSA-213406 (Reactome)
phosphorylated

PLC-gamma1 bound to

SLP-76		R-HSA-213407 (Reactome)
Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP1927"
Personal tools